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Summary: 
The Liprin-α family of scaffolding proteins is highly evolutionary conserved. While one 
homologue is present in invertebrates, it has diversified into four isoforms in 
mammals. In invertebrates, Liprin-α plays a crucial role in synapse assembly and 
maintenance as well as in synaptic vesicle trafficking. Little is known about the 
functional role of the four Liprin-α isoforms in the mammalian brain. The aim of this 
study was to examine the common and diverging properties of the four Liprin-α 
isoforms in order to gain insight into their role at the mammalian synapse. 
A comparative characterization of the structure of the human and mouse Liprin-α 
genes and their regulation by alternative splicing showed that even though the 
genomic organization of the four isoforms is very similar, Liprins-α can be modified 
differentially in a developmental manner.  
To study the spatiotemporal expression pattern of the four Liprin-α isoforms we 
generated isoform-specific peptide antibodies. All four Liprin-α proteins are 
expressed in most neuronal populations of the brain, but each Liprin-α protein is 
characterized by a distinct expression profile. In particular, the spatiotemporal 
expression pattern of Liprin-α1 stands out. Expression of the most abundant 
isoforms, Liprin-α2 and -α3, and the more weakly expressed Liprin-α4 is restricted to 
the brain and increases during development. In contrast, Liprin-α1 is expressed in all 
tissues tested, is present in glia, and has the highest expression level during 
development. The overlapping and distinct regional and subcellular localization of the 
Liprins-α indicates common as well as diverging functional roles. These results 
support the hypothesis that Liprin-α1 might play a role in organizing protein 
complexes that are involved in cell migration.  
Liprins-α are hypothesized to act as scaffolding proteins at the active zone. To gain a 
better understanding of the role of Liprin-α2 at the presynapse we analyzed its 
dynamics. We found that Liprin-α2 has a relatively slow turn-over which suggests 
that Liprin-α2 functions as a stably integrated scaffolding protein, thereby adding to 
the tenacity of the active zone.  
For further investigations into the role of Liprins-α we identified shRNAs to knock 
down single isoforms as well as a point mutation to disrupt Liprin-α - RIMα 
interactions.  
  V 
In summary, this study provides a thorough characterization of the Liprin-α family, 
and indicates a role in cell migration during brain development for Liprin-α1 and a 
role in synapse tenacity for Liprin-α2. 
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1 Introduction 
1.1 The synapse 
Chemical synapses are the sites of contact and communication between a neuron 
and its target cell and are characterized by their asymmetric nature (Fig. 1.1). On 
both sides of the synapse signal transduction takes place at specialized membrane 
subcompartments. There are highly organized structures consisting of unique 
proteinaceous networks. At the presynapse, the area at the plasma membrane where 
synaptic vesicle fusion takes place, is called the active zone (AZ). On the opposite 
side, at the synapse, the postsynaptic density (PSD) contains the neurotransmitter 
reception apparatus (Sudhof, 2004; Schoch and Gundelfinger, 2006; Sheng and 
Hoogenraad, 2007). The active zone and PSD are precisely aligned and connected 
by trans-synaptic proteins, which bridge the synaptic cleft.  
 
Fig.1.1: The chemical synapse 
(A), Electron micrograph of a mouse hippocampal synapse (primary culture). (B), Schematic 
drawing of an enpassant presynaptic bouton taken from Ziv and Garner (2008) New 
Encyclopedia of Neuroscience. 
 
Upon action potential arrival at the presynaptic bouton rapid fusion of synaptic 
vesicles (SVs) at the active zone is triggered as a response to Ca2+-influx through 
voltage-gated Ca2+-channels (Sudhof, 2004; Smith et al., 2008). Neurotransmitter is 
released into the synaptic cleft and bound by receptors in the PSD, where the 
chemical signal is converted to an electrical signal and is propagated. SVs are made 
available for this extremely fast fusion event at the active zone plasma membrane by 
consecutive events named docking and priming (Fig. 1.2). Following SV fusion 
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vesicle replenishment is mediated by different endocytotic mechanisms, e.g. clathrin 
mediated endocytosis and bulk endocytosis.  
 
Fig. 1.2: The synaptic vesicle cycle 
Taken from Basic Neurochemistry, 1999. 
1.2 The presynaptic active zone 
SV fusion takes place at a specialized domain of the plasma membrane, the active 
zone, which is tightly associated with an electron-dense structure, named cytomatrix 
at the active zone (CAZ). Fusion of SVs is extremely rapid and therefore needs to be 
tightly controlled. This poses specific requirements to the organization of the protein 
network at the active zone. In order to achieve the high speed, SVs need to be 
available in  close proximity to the voltage-gated Ca2+-channels as well as the 
required regulatory  proteins (Siksou et al., 2007). Whereas exocytosis takes place at 
the active zone, endocytosis occurs in the perisynaptic region. Therefore the spatial 
segregation of membrane domains for exo- and endocytosis needs to be defined. 
These specific challenges suggest the need for a specialized structure at the active 
zone. 
1.2.1. Models of the active zone structure 
In recent years the morphology of the active zone of different synapse types and 
organisms has been analyzed in multiple studies using electron microscopy (EM). 
These studies showed that active zone morphology could vary considerably between 
synape types as well as species. 
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Fig.1.3: Overview of the active zone ultrastructur of different species and 
synapse types 
(A), Neuromuscular junction (NMJ) terminal in C. elegans. (B), NMJ terminal in Drosophila 
with a dense projection called T bar (blue arrow). Retina: Tetrad synapse between 
photoreceptor and lamina monopolar cells. (C), Frog NMJ, where SV are docked to the 
plasma membrane through dense projections. (D), Triadic photoreceptor ribbon synapse 
between a rod photoreceptor and horizontal cell and a rod bipolar cell in rat. (E), Excitatory 
synaptic terminal in human hippocampus with two active zones (red arrows). On the left, 
diagrams of the active zone structure in the synaptic terminal electron microgrpahs are 
shown. All figures taken from (Zhai and Bellen, 2004). 
 
For invertebrates two main types of active zone morphology were observed. In C. 
elegans the active zone at the neuromuscular junction (NMJ) was shown to have a 
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plaque like shape layered along the presynaptic plasma membrane (Hallam et al., 
2002). In Drosophila a T-shaped dense projection, called T-bar, which extends into 
the presynaptic terminal and where SVs cluster around, was described for the NMJ, 
the tetrade synapse of the visual system as well as for a subset of CNS synapses. 
(Figure 1.3A, B) (Meinertzhagen, 1996). At the frog NMJ the active zone was shown 
to be layed out in a very organized, array like structure using EM tomography. So 
called beams and pegs connect SVs with putative Ca2+-channels, so that each 
docked SV is perfectly aligned with at least one Ca2+-channel (Figure 1.3C) (Harlow 
et al., 2001). In the mammalian visual system photoreceptor synapses are found to 
exhibit ribbons where SVs cluster around (Figure 1.3D) (Dick et al., 2003) while in 
classical EM studies of mammalian CNS synapses the active zone showed a regular 
arrangement of cone-shaped electron densities, that extended into the cytosol, the 
so-called presynaptic grid (Figure 1.3E, 1.4) (Gray, 1963; Bloom and Aghajanian, 
1968; Pfenninger et al., 1969). Since then, many anatomical studies followed and 
different approaches for enhancement of EM aiming at better resolution and sample 
preperation were pursued. Using high pressure freezing of sampels instead of 
formaldeyde fixation followed by EM, docked vesicles were also described to 
clusterer around electron-dense material at the active zone, but these structures 
were not arranged in a regular pattern (Siksou et al., 2007). In the most recent 
approach using cryo-electron-tomography, where samples are vitrified, no cone 
shaped electron densities could be detected at the active zone (Figure 1.4) 
(Fernandez-Busnadiego et al., 2010) .  
 
Fig. 1.4: Different models of the mammalian active zone ultrastructure 
(A), Model of the AZ derived from classical EM studies. (B), Model of the AZ derived from a 
high pressure freezing EM study by Siksou et al. (C), Reconstruction of a cryo electron 
tomograph of the presynaptic bouton viewed from the cytoplasmic side where AZ membrane 
densities are mapped Gray, AZ; yellow (partially transparent), proximal synaptic vesicles; 
blue, synaptic vesicle tethers; green, other densities on the AZ that do not contact the 
vesicles (Fernandez-Busnadiego et al., 2010). 
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Many of the described electron-dense projections were shown to tether vesicles. 
Most prominently this has been shown for the frog NMJ but also at the vertebrate 
synapse tethers linking the active zone and SVs were described using a variety of 
methods (Harlow et al., 2001; Siksou et al., 2007; Fernandez-Busnadiego et al., 
2010). 
At some specific synapses proteins that are essential for the morphology and 
function of the active zone were identified. For example the retina of the Bassoon 
knock out mouse exhibits a severe disruption of the photoreceptor ribbon synapse 
morphology. The number of ribbons is reduced and they are no longer anchored at 
the active zone (Dick et al., 2003). In Drosophila, mutants of the ELKS family 
member Bruchpilot are lacking the T-shaped electron dense projections at the 
tetrade synapse of the visual system as well as at larval NMJ and show deficits in 
Ca2+-channel clustering (Wagh et al., 2006). In C. elegans and Drosophila, mutants 
of the Liprin-α homolog (SYD-2/Dliprin-α) show a disrupted active zone morphology 
as well as an impairment of synaptic transmission at the NMJ (Zhen and Jin, 1999; 
Kaufmann et al., 2002). 
1.2.2. CAZ proteins 
Many proteins that are associated with the CAZ have been identified. Most of these 
proteins are not specifically localized at the active zone but are also found in other 
functional compartments of the cell. The CAZ is composed of cytoskeletal proteins, 
adhesion molecules, scaffolding proteins, voltage-gated Ca2+-channels and 
components of the fusion machinery. Only four families of proteins are known so far 
to be highly enriched at the active zone, i.e. RIM, Munc13, ELKS and 
Bassoon/Piccolo (Schoch and Gundelfinger, 2006). RIMs play an important role in 
linking SV to the Ca2+-channels and together with Munc13 are necessary for priming 
of SV (Schoch et al., 2002; Kiyonaka et al., 2007). ELKS, Bassoon and Piccolo are 
scaffolding proteins that interconnect many active zone proteins (Wang et al., 2009). 
Until now the molecular mechanisms underlying the organization of the active zone 
as well as the components essential for active zone formation and maintenance are 
unknown. A protein family enrichted at the active zone and implicated to play a role in 
active zone assembly are the Liprins-α. 
  INTRODUCTION 
 6 
1.3 Liprins-α 
The evolutionary conserved Liprin-α family of scaffolding proteins plays a crucial role 
in synapse assembly and function (Schoch and Gundelfinger, 2006; Spangler and 
Hoogenraad, 2007; Stryker and Johnson, 2007a). Liprins-α were originally identified 
by their interaction with the LAR-RPTPs (leukocyte common antigen-related family of 
receptor protein tyrosine phosphatases) in non-neuronal cells (Pulido et al., 1995; 
Serra-Pages et al., 1995). Whereas in the invertebrates C. elegans and Drosophila 
only a single Liprin-α gene was described, SYD-2 (synapse-defective-2) (Zhen and 
Jin, 1999) and Dliprin-α (Kaufmann et al., 2002), respectively, four Liprin-α isoforms 
were found in vertebrates, Liprin-α1, -α2, -α3 and -α4 (Serra-Pages et al., 1998). 
Liprins-α exhibit a striking degree of conservation, with 40% amino acid identity 
between the worm SYD-2 and human Liprin-α1. 
1.3.1. Liprin-α domains and their interaction partners 
Liprin-α proteins are composed of an N-terminal region predicted to form coiled-coil 
structures and three C-terminal SAM (sterile-α-motif)- domains that constitute the LH 
(liprin homology) region (Fig. 1.5A) (Pulido et al., 1995; Serra-Pages et al., 1995; 
Serra-Pages et al., 1998).  
 
 
A 
B 
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Fig.1.5: Liprins-α  domains and their putative interaction partners 
(A), Schematic drawing of the structural domains of Liprins-α. CC: Coiled-coil domain, S: 
SAM- (sterile-α-motive) domain. (B), Schematic drawing of the known interaction partners for 
Liprins-α at the pre- and postsynaptic side. In green: AZ enriched proteins. (C), Schematic 
drawing of the potential role of Liprin-α as an adaptor protein between Kif1A and its cargo. 
 
The SAM-domains have been reported to interact with the intracellular domain of 
LAR-RPTPs (Pulido et al., 1995), the MAGUK (membrane-associated guanylate 
kinase) protein CASK (calcium/calmodulin-dependent serine protein kinase) (Olsen 
et al., 2005; Samuels et al., 2007), CaMKII (Ca2+/calmodulin-dependent protein 
kinase II) (Hoogenraad et al., 2007), Liprin-ß and ATP (Serra-Pages et al., 2005). 
The N-terminal coiled-coil region mediates homo- and hetero-dimerization as well as 
interactions with various synaptic proteins, including the presynaptic active zone 
proteins RIM (Rab3-interacting molecule) (Schoch et al., 2002) and ELKS (also 
CAST/ERC (ELKS/RAB6-interacting/CAST)) (Ko et al., 2003a), the GTPase 
activating protein for the family of ADP-ribosylation factor GTPases GIT1 (G protein-
coupled receptor kinase interactor) (Ko et al., 2003b), and the kinesin motor protein 
KIF1A (kinesin family member 1A) (Shin et al., 2003). At their C-terminus vertebrate 
Liprins-α contain a PDZ-binding motif that interacts with GRIP (glutamate receptor 
interacting protein) (Wyszynski et al., 2002). Through these interactions Liprins-α are 
directly linked to essential components of the presynaptic active zone and the 
postsynaptic density (Fig. 1.5B) as well as the machinery required for vesicular 
transport. 
1.3.2. Functional role of Liprin-α  in C.elegans and Drosophila 
A loss of function mutant for the C. elegans Liprin-α homolog SYD-2 was identified in 
a genetic screen for mutations affecting the localization of a SV marker. These 
C 
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mutants showed a diffuse localization of SVs at the neuromuscular junction of motor 
neurons. In addition, the presynaptic Aactive zones were significantly lengthened 
while being less electron-dense. Mutants exhibited uncoordinated movement as well 
as defects in egg-laying behavior, indicative of a defect in synaptic transmission 
(Zhen and Jin, 1999). A subsequent study showed that SYD-2 is important for the 
correct localization of presynaptic proteins, e.g. ELKS, GIT SAD1, endophillin, RIM 
and synapsin (Ackley et al., 2005; Patel et al., 2006). Another candidate gene that 
was identified in the initial screen is SYD-1. SYD-1 loss-of-function mutants show a 
similar phenotyp as SYD-2 mutants. At the NMJ of SYD-1 mutants fewer presynaptic 
punta were detected and an abberant active zone shape was observed. Presynaptic 
proteins were diffusely distributed and mutants exhibited uncoordinated movement 
as well as defects in egg-laying behavior (Hallam et al., 2002). At HSN 
(hermaphrodite specific neurons) motorneurons that control egg-laying behaviour 
identical phenotypes of the SYD-1 and SYD-2 mutants were observed. In the SYD-1 
mutant the punctate pattern of SYD-2 is diffuse compared to wild type. For this set of 
neurons a gain of function mutation in SYD-2 was identified that was able to rescue 
the egg-laying phenotype (Dai et al., 2006). In these double mutants the presynaptic 
localization of SYD-2 is restored. In addition an increased interaction of SYD-2 with 
ELKS was observed. For the rescue of the SYD-1 mutant phenotype the presence of 
ELKS was critical. It was hypothesized that SYD-1 acts upstream of SYD-2 and is 
important for the precise localization of SYD-2 at the synapse, thereby promoting 
SYD-2 activity. 
Drosophila Dliprin-α mutants show a very similar defect in active zone morphology 
(Kaufmann et al., 2002). While at the wild type NMJ the size and shape of the active 
zone is very consistent, the loss of the functional Liprin-α homolog leads to elongated 
and larger active zone. The evoked excitatory junctional potentials and quantal 
content per synaptic event were decreased at the NMJ of Dliprin-α mutants pointing 
to a specific impairment of presynaptic function (Kaufmann et al., 2002). 
Furthermore, lack of Dliprin-α during synapse development at the larval NMJ lead to 
a reduction of bouton number and branch complexity of the terminal arbor (Kaufmann 
et al., 2002). This suggests that Dliprin-α plays an important role in synapse growth 
and thus in the formation of new boutons at the ends of terminal branches. 
Additionally, invertebrate Liprins-α are involved in the regulation of synaptic vesicular 
transport through their interaction with the motor protein KIF1A/UNC-104. In Dliprin-α 
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mutants SVs abberantly accumulate along the axon, indicating that Dliprin-α plays a 
role in trafficking of SVs (Miller et al., 2005). In C. elegans, Liprin-α controls motor 
clustering along axons as well as motor motility. Loss of SYD-2 binding reduces net 
anterograde movement and velocity of the cargo (Wagner et al., 2009). 
In the visual system Dliprin-α is required for the correct targeting of photoreceptor 
axons (Choe et al., 2006; Hofmeyer et al., 2006). Dliprin-α, N-cadherin and Dlar 
mutants show similar phenotypes in a set of photoreceptor cells (R1-6). The authors 
hypothesized that theses proteins act at the same step of axon targeting i.e. during 
target stabilization. A subsequent study showed that complex positive as well as 
inhibitory interactions amongst Dliprin-α, N-cadherin and DLAR regulate 
photoreceptor targeting (Prakash et al., 2009). During development of the visual 
system this protein complex regulates adhesive interactions between the pre- and 
post- synaptic cells at the axonal growth cone.  
1.3.3. Functional role of Liprins-α in mammals 
Mammalian Liprins-α were shown to be localized in axons and dendrites, in 
agreement with their association with pre- and postsynaptic protein complexes 
(Wyszynski et al., 2002). Liprins-α have been reported to regulate clustering and 
localization of LAR in cultured cell lines (Serra-Pages et al., 1995; Serra-Pages et al., 
1998). At the presynaptic active zone of primary neurons Liprins-α colocalize with 
ELKS and RIM, two interaction partners known to be highly enriched at the active 
zone. These two proteins link Liprins-α to the tight net of active zone proteins. 
Interestingly, in RIM1α as well ELKS knock out mice levels of Liprin-α are unchanged 
(Kaeser et al., 2008; Kaeser et al., 2009). In dendrites Liprins-α are key proteins for 
the dendritic targeting of AMPA receptors. Liprin-α forms a complex with GRIP-LAR 
and GluR2/3 and the interaction of Liprin-α with GRIP is important for surface 
expression of AMPA receptors (Wyszynski et al., 2002). In addition, interfering with 
the Liprin-α - GIT interaction leads to disruption of dendritic clustering and surface 
expression of AMPA receptors (Ko et al., 2003b). 
Furthermore, the Liprin-α-LAR-GRIP complex is involved in the development and 
maintenance of excitatory synapses as LAR mutants lead to decreased synapse 
density. The complex plays a role in the dendritic targeting of cadherin-ß-catenin, 
which is dependent on LAR phosphatase activity (Dunah et al., 2005). Recently, the 
interactions between Liprin-α, GRIP and the AMPA receptor subunit GluR2 were 
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identified as required for muscarinic receptor-triggered long term depression (LTD) 
(Dickinson et al., 2009). 
A first study addressing possible functional differences of the four Liprin-α isoforms 
reported that Liprin-α1 is regulated in an activity-dependent manner. Liprin-α1 but not 
Liprin-α2 was degraded either in response to CaMKII phosphorylation or via the E3 
ubiquitin ligase anaphase promoting complex (APC) (Hoogenraad et al., 2007). 
Expression of non-degradable Liprin-α1 mutants resulted in impaired dendritic 
targeting of LAR and a reduction of dendritic branching and synapse number.  
Outside the nervous system Liprins-α have been found to localize LAR to the 
proximal edge of focal adhesions of human cell lines (Serra-Pages et al., 1995). 
Increasing evidence suggest that Liprin-α1 plays a role in the dynamic regulation of 
focal adhesions during cell motility. Depletion of Liprin-α1 inhibits cell spreading while 
overexpression enhances motility as well lamellipodia and focal-adhesion formation 
at the cell edge. Increased levels of Liprin-α1 lead to a redistribution of inactive, low-
affinity integrins to focal adhesions while depletion increases the rate of integrin 
internalization. This indicates that Liprins-α regulate focal adhesion turn-over by 
influencing the localization and stability of integrins (Shen et al., 2007; Asperti et al., 
2009; Asperti et al., 2010).  
 
Taken together, Liprins-α are critically involved in the assembly, organization and 
function of presynaptic active zones, in the development and maintenance of 
dendritic spines and excitatory synapses and in the regulation of vesicular trafficking 
and cell motility.  
1.4 Assembly of the active zone 
Synapse assembly, i.e. the establishment of an axo-dendritic contact and the 
assembly of the active zone and postsynaptic density, is a key process during 
synaptogenesis as well as synaptic plasticity. In recent years genetic studies in 
invertebrates and vertebrates have allowed first insights into the formation of the 
active zone. Dissecting the underlying processes of synapse assembly has proven 
difficult among others due to genetic redundancies.  
Establishing a synaptic contact is a multi-step process. First contact and recognition 
of an axon and dendrite takes place. Then the essential modules necessary to build 
a synapse e.g. the active zone components, the exo- and endocytosis machinery, the 
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components of the PSD and the trans-synaptic adhesion molecules need to be 
assembled at the site of contact. Many findings indicate that the assembly of these 
modules takes place by self-assembly of units (Owald and Sigrist, 2009).  
The assembly is best studied in the model organisms C. elegans and Drosophila. 
Several presynaptic proteins important for the regulation of active zone formation 
were identified (Fig. 1.6). In C. elegans the definition of a patch of membrane where 
the active zone is assembled is dependent on the immunoglobulin cell adhesion 
molecules (IgCAM) UNC-44/DCC or the hetrophilic interaction pair SYG-1/Neph1 
and SYG-2/Nephrin in different synapses (Shen et al., 2004; Colon-Ramos et al., 
2007; Chao and Shen, 2008). Other IgCAM proteins might have similar functions in 
Drosophila and vertebrates. The cell adhesion molecules that trigger initial assembly 
seem to have diverged between synapse types and species.  
Following the trans-synaptic interaction of the IgCAMs SYG-1 and SYG-2, which 
define the sites of active zone assembly, these proteins then recruit SYD-1 and SYD-
2. SYD-2 in turn localizes other proteins such as ELKS and RIM to the active zone. 
SYD-1 and SYD-2/Liprin-α are key molecules that are tightly regulated to ensure 
correct assembly of the active zone. Their protein levels are critical for normal active 
zone size. RSY-1 (regulator of synaptogenesis-1), a protein identified in a genetic 
screen for mutants that rescue the synaptic phenotype of SYD-1 mutants, directly 
interacts with and regulates SYD-1 and SYD-2 (Patel and Shen, 2009). RSY-1 locally 
inhibits synapse assembly through negatively regulating these key assembly 
molecules. In Drosophila it was shown that presynaptic Dliprin-α levels, which are 
critical for normal active zone size are regulated through ubiquitylation by the 
ubiquitin-ligase APC/C (anaphase-promoting complex/cyclosome) (van Roessel et 
al., 2004). This allows regulation of the size of the presynaptic active zone by 
regulation of Dliprin-α through APC/C. 
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Fig.1.6: Molecular mechanisms involved in active zone assembly 
A cartoon depicting proteins implicated in active zone assembly in different model organisms.  
Type of interactions are indicated by letters above the arrows: I = direct physical interaction, 
G = genetic interaction/ regulation inferred from genetic findings. Dashed lines indicate 
indirect evidence of interaction from imaging data. Figure taken from (Owald and Sigrist, 
2009). 
 
To better understand the modular assembly of the synapse different studies were 
carried out to define the time course. While cell culture experiments suggested a very 
rapid assembly in the course of 1-3 hours, data from slice cultures indicated that 
establishing a functional synapse takes many hours to one day (Owald and Sigrist, 
2009). A recent study using time lapse imaging and electrophysiological analysis 
C. elegans 
 
Drosophila 
 
Mammals 
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followed by EM showed that synapses formed in the time frame of a few hours after 
spine formation occurred (Zito et al., 2009). There are different possible explanations 
for the differing results from the two systems. Synaptogenesis could be more tightly 
regulated in the slice and in addition the course of assembly might differ between 
high activity and low activity situations. 
 
In summary, in invertebrates Liprin-α is a master assembly molecule that recruits 
numerous synaptic components to presynaptic sites as a result of contact initation by 
IgCAMs. To assure correct assembly of the active zone Liprin-α is regulated on 
different levels. At the mammalian synapse even though multiple components of the 
active zone have been described, no component critical for the assembly was yet 
identified.  
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1.5 Aims of this study 
Liprins-α are a highly evolutionary conserved protein family with one homolog 
present in invertebrates and four isofoms in mammals. Studies in invertebrates 
showed that Liprins-α play a key role in synapse assembly and maintenance as well 
as in synaptic vesicle (SV) trafficking. So far little is known about the role of this 
protein family in the mammalian synapse. The aim of this study is to gain a better 
understanding of the role of Liprins-α at the mammalian synapse and to resolve the 
similarities and differences on the level of expression as well as function of the four 
isoforms. 
Our first objective is to thoroughly characterize the genetic structure of the 
mammalian gene family as well as their alternative splicing as a way to obtain first 
insights into possible differences between the four isoforms. To verify our 
bioinformatic analysis we will subclone all four Liprin-α cDNAs and verify the sites of 
alternative splicing using RT-PCR. 
So far no isoform specific antibodies are available, thus our second aim is to 
generate isoform specific antibodies to be able to dissect the distribution of the four 
isoforms on the cellular and subcellular level using immunoblots as well as 
immunostainings of primary neurons and brain sections. 
In invertebrates the lack of Liprin-α led to a disruption of active zone morphology, 
mislocalization of other presynaptic proteins as well as to defects in synaptic vesicle 
trafficking. To be able to analyze the functional role of the family of Liprins-α and to 
study if Liprins-α fulfill a similar role in mammals we plan to develop tools to interfere 
with Liprin-α function. We would like to use shRNAs to analyze the effect of the lack 
of single Liprins-α on cell morphology as well as localization of other presynaptic 
proteins. In addition, we aim to identify point mutations to inhibit specific interactions. 
Disrupting interactions with specific binding partners would allow for a dissection of 
the functional role of these interactions. 
Liprins-α are hypothesized to operate as scaffolds at the active zone (AZ), the site of 
synaptic vesicle fusion at the presynapse. Employing time-lapse imaging allows to 
study the dynamics of individual proteins and thus gives insights into their role at the 
presynapse. We plan to elucidate the turn over of Liprins-α at the presynapse by 
using FRAP (fluorescent recovery after photobleaching) and FRAPA (fluorescent 
recovery after photoactivation) experiments. 
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2 Materials  
2.1 Equipment 
Application Model Company 
Acrylamid electrophoresis 
system  
Mini-PROTEAN 3 
Electrophoresis System 
BioRad 
 
Agarose 
electrophoresissystem SUB-CELL GT  BioRad 
Analytical balance BP210S Sartorius 
Autoclave Varioklav 75T H + P 
Balance SBC53 SCALTEC 
Capillary Sequencer 
3130/xl/Genetic 
Analyzer 
Applied Biosystems 
Cell-cultur hood MSC-Advantage Thermo Scientific 
Centrifuge 1-15K Sigma 
Centrifuge 5415C Eppendorf 
Centrifuge  Micro 22R  Hettich 
Centrifuge  Avanti J-20  Beckman Coulter 
Confocal laser scanning 
microscop Leica TCS Leica 
Confocal laser scanning 
microscop  LSM710 Zeiss 
Cryostat FV300 MICROM 
Gel documentation system AlphaImager Alpha Innotech 
Incubator T6 Heraeus Instruments 
Infrared imaging system Odyssey Li-cor 
Inverse microscope Axio Observer 1A Zeiss 
PCR-Cycler UNOII Biometra 
PCR-Cycler MY Cycler Biorad 
Real time PCR (Taqman)  9700HT ABI Prism 
pH-meter HI 9025 HANNA Instruments 
Photometer BIO Eppendorf 
Spectrophotometer ND-1000 NanoDrop 
Thermo shaker MK13 HLC 
Transfer System Mighty Small Transphor/Hoefer TE22 Amersham 
Ultrasonicator  UP50H Hilscher 
Vortex  Vortex-Genie 2 Scientific Industries 
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2.2 Material and Reagents  
2.2.1. Antibodies 
Table 3.1: Primary antibodies 
Antibody Assay Dilution Company 
Bassoon  
(clone SAP7F407) 
ICC 1:200-400 Stressgen 
ß-actin WB 1:5000 Abcam 
CtBP2 ICC 1:10000 BD Bioscience 
GAD 67 ICC 1:400 Chemicon 
GAPDH WB 1:1000 Abcam 
GFAP ICC 1:400 Synaptic Sytems 
GFP (T3743) WB 1:3000 Südhof lab 
HA WB 1:5000 Sigma 
Liprin-α1 ICC/IHC/WB 1:20/1:50/1:100 Pineda 
Liprin-α2 ICC/IHC/WB 1:50/1:50/1:200 Pineda 
Liprin-α3 ICC/IHC/WB 1:20/1:50/1:200 Pineda 
Liprin-α4 ICC/IHC/WB 1:20/1:50/1:200 Pineda 
Pan-Liprin-α WB 1:10000 Südhof lab 
PSD-95 ICC 1:200 Chemicon 
RIM1α ICC 1:100 BD Bioscience 
Synaptophysin IHC 1:200 Synaptic Systems 
 
Table 3.2: Secondary antibodies 
Antibody Assay Dilution Company 
anti-mouse Cy5 ICC/IHC 1:200 Jackson immuno reagents Europe Ltd 
anti-rabbit Alexa 594 ICC/IHC 1:1000 Molecular Probes 
anti-rabbit Alexa 488 ICC/IHC 1:100 Invitrogen 
IRDye anti-mouse 680nm WB 1:20.000 Licor 
IRDye anti-rabbit 800nm WB 1:20.000 Licor 
horseradish peroxidase 
coupled anti-mouse WB 1:3000 
Jackson immuno reagents 
Europe Ltd 
horseradish peroxidase 
coupled anti-rabbit  WB 1:3000 
Jackson immuno reagents 
Europe Ltd 
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2.2.2. Cell culture media 
Dulbecco's Modified Eagle's Medium  (DMEM)   Gibco BRL 
Basal Medium Eagle  (BME)   Invitrogen 
IMDM  Gibco BRL 
Fetales calf serum  (FCS)   Invitrogen 
Opti-MEM          Gibco BRL 
Phospate saline buffer  (PBS)      Gibco BRL 
Hank's Buffered Salt Solution  (HBSS)     Gibco BRL 
Penicillin-Streptomycin       Gibco BRL 
Glucose   Invitrogen 
B27   Invitrogen 
2.2.3. Chemicals 
Chemicals were ordered from standard sources (Roth, Sigma-Aldrich, Merck). 
 
Bovine serum albumin (BSA)   Sigma Aldrich 
Cold water fish gelantine   Sigma 
Complete Protease Inhibitor Cocktail Tablets   Roche 
DMSO   Roth 
Fetal calve serum (FCS)   Invitrogen 
Glutathion   Sigma 
Milk powder   Roth 
Normal goat serum (NGS)   GIBCO BRL 
Paraform aldehyd (PFA)   Merck 
Poly-L-lysine   Sigma 
Triton X-100   Sigma 
Vectashield mouting medium  Vector Laboratories 
2.2.4. Diverse materials 
Glutathion-agarose beads      Sigma-Aldrich 
HyperFilm        Amersham 
Nitrocellulose membrane (Protan 0,4 mm) Watman, GE Healthcare 
Tissue tek       Sakura Finetek 
 
 
 
 
 
  MATERIALS 
 18 
2.2.5. Enzymes 
GoTaq   Promega 
pfu DNA polymerase  Promega 
Restriction enzymes:  
BamHI, EcoRI, HindIII, KpnI, Xho  Fermentas 
BamHI, BglII, PacI  New England Biolabs 
Trypsin  GIBCO BRL 
T4 Ligase  Fermentas 
2.2.6. Kits 
Amersham ECL Plus Western  GE Healthcare Europe 
BigDye Terminator v3.1cycle Sequencing kit  Applied Biosystems 
Blotting Detection Reagents GE Healthcare Europe 
DNA Clean and Concentration kit  Zymo Research 
DyeEx 2.0 (Purification of Sequencing) Qiagen 
GeneJET Plasmid Miniprep kit Fermentas 
iScript cDNA synthesis kit Biorad 
Lipofectamine 2000  Invitrogen 
Long PCR Enzyme Mix  Fermentas 
QuickChangeII XL Site Directed Mutagenesis kit Stratagen 
PRISM  Big Dye  Terminator (Sequencing) Applied Biosystems 
Pure link Midi kit (DNA purification) Invitrogen 
TOPO vectors  Invitrogen 
RNeasy Lipid Tissue Kit Qiagen 
Superscript RT III kit Invitrogen 
SYBR Green PCR kit  Qiagen 
Zymoclean Gel DNA recovery kit Zymo Research 
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2.3 Oligonucleotides 
For all oligonucleotides the entry number under which it is listed in our data bank is 
stated (#). 
2.3.1. Cloning  
Table 3.3: Primers used for cloning of full length Liprins-α. 
Gen  # 5 ́-SEQUENCE-3 ́ Vector 
Liprin-α1  fw 900 CCCGCCGGCCAAGATGATGT pcDNA 3.1-TOPO 
Liprin-α1  rev 903 ATGTGGTTGGGGTAAGGGCTGTT pcDNA 3.1-TOPO 
Liprin-α2  fw 984 TCTTTCTCCTCCCGTTGCTA pcDNA 3.1-TOPO 
Liprin-α2  rev 985 TTGAGCCATCACAGTGCTTC pcDNA 3.1-TOPO 
Liprin-α3  fw 904 CCCCGGGGAACACGAGACTTAG pcDNA 3.1-TOPO 
Liprin-α3  rev 907 GCCCCCTTTCAGTCCATTTCTTA pcDNA 3.1-TOPO 
Liprin-α4  fw 650 CCCCTGACCCGACGCTGAGA pcDNA 3.1-TOPO 
Liprin-α4  rev 651 CGGGCTTGAGGACGGGTAGTTG pcDNA 3.1-TOPO 
 
Table 3.4: Primers used for cloning of constructs for pull down assay to test the 
interaction of GRIP with the alternatively spliced C-termini of Liprin-α1 and -α4. 
Gen  # 5 ́-SEQUENCE-3 ́ Vector 
Liprin-α1a fl  fw 1156 CCGGCCAAGATGATGTGC pcDNA6.2 N-termGFP TOPO 
Liprin-α1a fl  rev 1158 CTAGCAGGAGTAAGTCCTGACTGT pcDNA6.2 N-termGFP TOPO 
Liprin-α1b C-term. fw 1274 TGGAGGAAGAAGTTCAGACCA NT-GFP Fusion TOPO TA 
Liprin-α1b C-term. rev 1275 CATCTGTAGAAGTAGTGTGGG NT-GFP Fusion TOPO TA 
Liprin-α4b fw 1168 TCCATTCCCATCATGTGTGAGG pcDNA6.2 N-termGFP TOPO 
Liprin-α4b  rev 1169 GGGGGTCAGCAGGAGTAGGTC pcDNA6.2 N-termGFP TOPO 
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Table 3.5: Primers for cloning of deletion constructs and constructs for time-lapse 
imaging. RE: restriction enzyme. 
Gen Domain  # 5 ́-SEQUENCE-3 ́ RE Vector 
GFP  GFP N-term. fw fw 819 
GGCGGTACCGGTCGCCAC
CATGGT KpnI pCMV 
GFP  GFP N-term. rev rev 1134 
GGCGGTACCCTCCTCCCT
TGTACAGCTCGTCCATGC
CG 
KpnI pCMV 
paGFP  paGFP N-term. fw fw 819 
GGCGGTACCGGTCGCCAC
CATGGT KpnI pCMV 
paGFP  paGFP N-term. fw rev 1134 
GGCGGTACCCTCCTCCCT
TGTACAGCTCGTCCATGC
CG 
KpnI pCMV 
GFP  GFP N-term. fw fw 1272 
GGCGAATTCACCGGTCGC
CACCATGGT EcoRI pCMV-RIM1α 
GFP  GFP N-term rev rev 1273 
GGCCTCGAGCACCCTCCT
CCCTTGTACAGCTCGTCCA
TGCCG 
XhoI pCMV-RIM1α 
Cherry  Cherry N-term. fw fw 1272 
GGCGAATTCACCGGTCGC
CACCATGGT EcoRI pCMV-RIM1α 
Cherry  Cherry N-term. rev rev 1273 
GGCCTCGAGCACCCTCCT
CCCTTGTACAGCTCGTCCA
TGCCG 
XhoI pCMV-RIM1α 
paGFP paGFP N-term. fw fw 1272 
GGCGAATTCACCGGTCGC
CACCATGGT EcoRI pCMV-RIM1α 
paGFP  paGFP N-term. rev rev 1273 
GGCCTCGAGCACCCTCCT
CCCTTGTACAGCTCGTCCA
TGCCG 
XhoI pCMV-RIM1α 
Liprin-
α2 Full lenth fw 1208 
GGCAGATCTCAATGATGT
GTGAAGTGATGCCC BglII 
pCMVMCS N-
term. GFP 
Liprin-
α2 Full lenth rev 1228 
GGCTTAATTAATCAACATG
AGTATGTGCGAAC PacI 
pCMVMCS N-
term. GFP 
Liprin-
α2 Full lenth fw 1208 
GGCAGATCTCAATGATGT
GTGAAGTGATGCCC BglII 
pCMVMCS N-
term. paGFP 
Liprin-
α2 Full lenth rev 1228 
GGCTTAATTAATCAACATG
AGTATGTGCGAAC PacI 
pCMVMCS N-
term. paGFP 
Liprin-
α2 
N-term. 
half  fw 1241 
GGCAGATCTACATGATGT
GTGAAGTGATGCCCACG BglII 
pCMV-GFP N-
term. 
Liprin-
α2 
N-term. 
half  rev 1242 
GGCTTAATTAAACGGCTCT
GGGTGTTGG PacI 
pCMV-GFP N-
term. 
Liprin-
α3 
CC 
domain fw 1136 
GGCAGATCTACCATGGGA
ATGACTGTGGTGAAACGC
C 
BglII pCMV-GFP N-term. 
Liprin-
α3 
CC 
domain  rev 1137 
GGCTTAATTAATCGGCCTA
TGGACGACTTGAT PacI 
pCMV-GFP N-
term. 
Liprin-
α2 
C-term. 
half  fw 1239 
GGCAGATCTCAGCCGTCA
GAATGACTCACAC BglII 
pCMV-GFP N-
term. 
Liprin-
α2 
C-term. 
half  rev 1240 
GGCTTAATTAATCAACATG
AGTATGTGCGAACAGTGG PacI 
pCMV-GFP N-
term. 
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Table 3.6: Primers used for constructs employed in pull down assays to test effect of 
point mutations on Liprin-α- RIM1α interaction. RE: restriction enzym 
Gen Domain  # 5 ́-SEQUENCE-3 ́ RE Vector 
Liprin-α2 RBD  fw 1429 GCGAGATCTACCACAAAGCCTTGGATGAA BglII 
pCMV-HA 
N-term. 
Liprin-α2 RBD rev 1430 GCGTTAATTAATATTGGCCCTCGAGGTGTCTCATAC PacI 
pCMV-HA 
N-term. 
Liprin-α2 RBD  fw 1556 GCGGGATCCAGAGTCTCTGCACTGGAAGAGG BamHI pGEX-KG 
Liprin-α2 RBD  rev 1557 GCGAAGCTTAGCGCAAGATGGCTTCCTTGT HindIII pGEX-KG 
RIM1α C2B fw 1431 GCGAGATCTTGTCGGGCCACAAGAAGTTG BglII 
pCMV-HA 
N-term. 
RIM1α C2B rev 1432 GCGTTAATTAACTATGACCGGATGCAGGGAG PacI 
pCMV-HA 
N-term 
2.3.2. Diverse oligos 
Table 3.6: Primers for cloning of peptides used for affinity anaysis of newly generated 
Liprin-α antibodies. 
Ab peptid   # 5 ́-SEQUENCE-3 ́ Vector 
Liprin-α1 fw fw 1634 GATCCAGCCATGGGTCAGGCTCCCCTTCACAGCCAGATGCTGATTCGCATTTTGAGA pGEX-KG 
Liprin-α1 rev rev 1635 AGCTTCTCAAAATGCGAATCAGCATCTGGCTGTGAAGGGGAGCCTGACCCATGGCTG pGEX-KG 
Liprin-α2 fw fw 1636 GATCCTCTTCCTACCACAATGATGCCCGGAGCAGTTTATCTGCCTGCA pGEX-KG 
Liprin-α2 rev rev 1637 AGCTTGCAGGCAGATAAACTGCTCCGGGCATCATTGTGGTAGGAAGAG pGEX-KG 
Liprin-α3 fw fw 1638 GATCCCGGGGAAGGCCGCCCTCCTCCTATTCCAGGTCCCTTCCTGGCAGTTGCA pGEX-KG 
Liprin-α3 rev rev 1639 AGCTTGCAACTGCCAGGAAGGGACCTGGAATAGGAGGAGGGCGGCCTTCCCCG pGEX-KG 
Liprin-α4 fw fw 1640 GATCCGAGGGGGACCCCCTGGGGCCCCCCCACGGTGCCGATGCTGAGGCCAACTTTGAGA pGEX-KG 
Liprin-α4 rev rev 1641 AGCTTCTCAAAGTTGGCCTCAGCATCGGCACCGTGGGGGGGCCCCAGGGGGTCCCCCTCG pGEX-KG 
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Oligo # 5 ́-SEQUENCE-3 ́ Vector 
MCS fw 1024 AATTGGCGCGCCGGTACCGGATCCATCGATTTAA
TTAAGAATTCGCGATCGCT 
pCMV5 
MCS rev 1025 GATCAGCGATCGCGAATTCTTAATTAAATCGATGG
ATCCGGTACCGGCGCGCC 
pCMV5 
HA N-term. fw 1427 CATGTACCCATACGATGTTCCAGATTACGCTCCCG
GTCCCGGGTAC 
pCMV5-
MCS 
HA N-term. rev 1428 CCGGGACCGGGAGCGTAATCTGGAACATCGTATG
GGTACATGGTAC 
pCMV5-
MCS 
Exon 
 
# 5 ́-SEQUENCE-3 ́ 
Position 
(bp) 
Liprin-α1 exon10 fw 1170 GCACCGACAGACAGAAGACA 1276 
Liprin-α1 exon10  rev 1171 GCTGCAGCTCCTGATTTTTC 1577  
Liprin-α1 exon18 fw 1097 GAAGGGTCCCTCACAGTCCT 2391  
Liprin-α1 exon18  rev 1098 GGGGGAGAGGTTTCACATTT  2541  
Liprin-α1 exon 24/25  fw 1101 GCTGGCCATCCAAGAGATAA 3118  
Liprin-α1 exon 24/25  rev 1102 GGTTCATGTCCCCATATGCT 3296  
Liprin-α1 exon 31 fw 1106 TTTTGATCACGGGGACTGAT 3756  
Liprin-α1 exon 31  rev 1107 TTGCCAGACGAGCTCTACAC 4092  
Liprin-α2 exon 6  fw 990 AAGAATGACGGTGGTCAAGC 711  
Liprin-α2 exon 6  rev 1130 GAACATTTTGCTCACGCAAG 928  
Liprin-α4 exon 22 fw 1124 TCAGCTCCACCTACCTCCAG 3100  
Liprin-α4 exon 22  rev 1125 ATTCGTTTCCAATCCACTCG 3259  
Liprin-α4b exon 28 fw 1174 ACCATAGCGGTGGCATGT 3794  
Liprin-α4b exon 28  rev 1175 GGAGAGCATGTGTCCGTAGAG 4056  
Liprin-α4b exon 28  fw 1174 ACCATAGCGGTGGCATGT 3794  
Liprin-α4b exon 28  rev 1175 GGAGAGCATGTGTCCGTAGAG 4056  
Liprin-α4 exon 22  fw 1124 TCAGCTCCACCTACCTCCAG 3100  
Liprin-α4 exon 22  rev 1125 ATTCGTTTCCAATCCACTCG 3259  
Liprin-α4b exon 28  fw 1174 ACCATAGCGGTGGCATGT 3794  
Liprin-α4b exon 28  rev 1175 GGAGAGCATGTGTCCGTAGAG 4056  
Liprin-α4b exon 28  fw 1174 ACCATAGCGGTGGCATGT 3794  
Liprin-α4b exon 28  rev 1175 GGAGAGCATGTGTCCGTAGAG 4056  
Table3.8: Oligonucleotides used to insert multiple cloning site (MCS) or HA-tag into 
a pCMV vector. 
Tabel 3.7: Position and sequence of primers for detection of alternative splicing. 
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2.3.3. Sequencing primer 
Table 3.9: Sequencing Primers 
Template  # 5 ́́-SEQUENCE-3 ́ Position (bp) 
pAMU6  fw 1637(B) TACGATACAAGGCTGTTAGAGAG  
pCMV5  fw pCMVF CCAAAATGTCGTAATAACCCCG 822 
pCMV5  rev pCMVR AGGACACCTAGTCAGACAAAATGATG 1076 
pGEX-KG  fw 319 GGGCTGGCAAGCCACGTTTGGTG 869 
pGEX-KG  rev 320 CCGGGAGCTGCATGTGTCAGAGG 1056 
GFP  fw GF-fw CATGGTCCTGCTGGAGTTCGTG  
Liprin-α1 fw 1007 ACCACAAAGCCTTGGATGAG 509 
Liprin-α1 fw 997 ATAGACAGGCAGGCGAGAGA 772 
Liprin-α1 fw 998 GCCTGTCTGACACTGTGGAT 1419 
Liprin-α1 fw 1084 TTGGACAATCTTGGTCGTTTT 2077 
Liprin-α1 fw 1085 GGGAGGACAAGCTGAGAAAA 2646 
Liprin-α1 fw 999 TAGAGCTCTGGGTTGGGATG 2762 
Liprin-α1 fw 1000 TCTGGCTTTGGACGAGACTT 3438 
Liprin-α2 fw 1038 CCCTACCTCAGGACATCGAA 239 
Liprin-α2 fw 990 AAGAATGACGGTGGTCAAGC 456 
Liprin-α2 fw 991 GTGGGAGAGGTGGAACAAGA 892 
Liprin-α2 fw 1086 TGGAGAAGCGTTACCTGAGTG 1028 
Liprin-α2 fw 992 ATGGCTGCTTTGGAAGAGAA 1462 
Liprin-α2 fw 994 GAGACTTCTCCTCCCCCAAC 2314 
Liprin-α2 fw 995 TGCCATCATGTCAGCGTTAT 2784 
Liprin-α2 fw 996 TCGGGAATATGCAAACAACA 3366 
Liprin-α2 fw 1087 GCCTTTGTGAAGACTGAATCC 3870 
Liprin-α3 fw 1088 ATCGCTCTGCCTCAGGAGTT 226 
Liprin-α3 fw 1089 GAGCTGGAGGAAGCTCTGG 709 
Liprin-α3 fw 1090 CAGCTGGAGGAGAAGAACCA 1213 
Liprin-α3 fw 1091 GAGAGCTGGATGGCTCAGAT 1715 
Liprin-α3 fw 1008 CTGCCCGTCTTGAGAGGAT 2162 
Liprin-α3 fw 1092 GCCATTCAGGAGATGGTGTC 2689 
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Template  # 5 ́́-SEQUENCE-3 ́ Position (bp) 
Liprin-α3 fw 1093 TGGCTCTGGATGAAACCTTC 3215 
Liprin-α4 fw 1009 CAGGTGTCTCCAGTGAGGTG 425 
Liprin-α4 fw 1003 TGACTGAGCTGGAGGAGGAC 767 
Liprin-α4 fw 1004 ACCGGTTGCTTAGTGAGTCC 1283 
Liprin-α4 fw 1005 AGATTGAGACCCGTGTGACC 1811 
Liprin-α4 fw 1010 GACCCACGAAGAGATGGAAA 2739 
Liprin-α4 fw 1006 GGATCACCTCACCAAGAAGG 2925 
Liprin-α4 fw 1094 ACCATAGCGGTGGCATGTT 3389 
Liprin-α4 fw 1095 TGGACTAATTGGCCTTCTGG 3967 
Liprin-α4 fw 1096 GGCTTCCCCTTTAGTGACTC 4438 
2.3.4. Site directed mutagenesis 
Table 3.10: Primers for site directed mutagenesis 
Template  # 5 ́-SEQUENCE-3 ́ Domain/ aa exchange 
pCMV-MCS-N-
term. Liprin-α2 fw 1415 
GAACGGTTAACAGCTGACTCTTCCCG
GGTGGG 
RBD 
294 L->D 
pCMV-MCS-N-
term. Liprin-α2 rev 1416 
CCCACCCGGGAAGAGTCAGCTGTTAA
CCGTTC 
 
pCMV-MCS-N-
term. RIMα1  fw 1423 
CCTGTATAGCCAAAAAGAAGGCAAGA
ATTGCACGGAAAACT 
C2B 
1454 T->A 
pCMV-MCS-N-
term. RIMα1 rev 1424 
AGTTTTCCGTGCAATTCTTGCCTTCTT
TTTGGCTATACAGG 
 
pCMV-MCS-N-
term. RIMα1 fw 1425 
CTCTAGATCCTTTGTATCAGGCGTCC
CTGGTTTTTGATGAAA 
C2B 
1467 Q->A 
pCMV-MCS-N-
term. RIMα1  rev 1426 
TTTCATCAAAAACCAGGGACGCCTGA
TACAAAGGATCTAGAG 
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2.3.5. shRNA constructs 
Table 3.11: Oligos for shRNA constructs 
Target  # Oligo Vector 
Liprin-α1 fw 1469 GATCTCGAAAGATTAGCAGAAGAAATTCAAGAGAT
TTCTTCTGCTAATCTTTCTTTTTTGGAAA 
pAMU6 
Liprin-α1 rev 1469 AGCTTTTCAAAAAGAAAGATTAGCAGAAGAAATCT
CTTGAATTTCTTCTGCTAATCTTTCCGA 
pAMU6 
Liprin-α2 fw 1468 GATCTCGACCAACTTGTCGTGACTATTCAAGAGAT
AGTCACGACAAGTTGGTCTTTTTTGGAAA 
pAMU6 
Liprin-α2  rev 1468 AGCTTTTCAAAAAAGACCAACTTGTCGTGACTATC
TCTTGAATAGTCACGACAAGTTGGTCCGA 
pAMU6 
Liprin-α2 fw 1652 GATCTCGCTCAGGCTAGCTATCCAATTCAAGAGAT
TGGATAGCTAGCCTGAGCTTTTTTGGAAA 
pAMU6 
Liprin-α2  rev 1653 AGCTTTTCAAAAA GCTCAGGCTAGCTATCCAA  
TCTCTTGAATTGGATAGCTAGCCTGAGCGA 
pAMU6 
Liprin-α2 fw 1654 GATCTCGGACAGAAGGCTGAAGAAATTCAAGAGA
TTTCTTCAGCCTTCTGTCCTTTTTTGGAAA 
pAMU6 
Liprin-α2 rev 1655 AGCTTTTCAAAAAGGACAGAAGGCTGAAGAAATCT
CTTGAATTTCTTCAGCCTTCTGTCCGA 
pAMU6 
Liprin-α2 fw 1656 GATCTCGCCAAGATTCTCTCCACAAAGTTCAAGAG
ACTTTGTGGAGAGAATCTTGGCTTTTTTGGAAA 
pAMU6 
Liprin-α2  rev 1657 AGCTTTTCAAAAAGCCAAGATTCTCTCCACAAAGT
CTCTTGAACTTTGTGGAGAGAATCTTGGCGA 
pAMU6 
Liprin-α2 fw 1658 GATCTCGCTATCCAAGAGATGGTTTCTTTCAAGAG
AAGAAACCATCTCTTGGATAGCTTTTTTGGAAA 
pAMU6 
Liprin-α2 rev 1659 AGCTTTTCAAAAAGCTATCCAAGAGATGGTTTCT 
TCTCTTGAAAGAAACCATCTCTTGGATAGCGA 
pAMU6 
Liprin-α3 fw 1642 GATCTCGACCACAATAAGCGACTGTCATTCAAGAGATG
ACAGTCGCTTATTGTGGTCTTTTTTGGAAA 
pAMU6 
Liprin-α3 rev 1643 AGCTTTTCAAAAAGACCACAATAAGCGACTGTCATCTC
TTGAATGACAGTCGCTTATTGTGGTCGA 
pAMU6 
Liprin-α3 fw 1644 GATCTCGGTTACAGCTTCACCTCAAAGTTCAAGAGACT
TTGAGGTGAAGCTGTAACCTTTTTTGGAAA 
pAMU6 
Liprin-α3 rev 1645 AGCTTTTCAAAAAGGTTACAGCTTCACCTCAAAGTCTCT
TGAACTTTGAGGTGAAGCTGTAACCGA 
pAMU6 
Liprin-α3 fw 1646 GATCTCGAGCATCAAGTCGTCCATATTCAAGAGATATG
GACGACTTGATGCTCTTTTTTGGAAA 
pAMU6 
Liprin-α3 rev 1647 AGCTTTTCAAAAAGAGCATCAAGTCGTCCATA 
TCTCTTGAA TATGGACGACTTGATGCTCGA 
pAMU6 
2.4 Vectors and vector construction 
2.4.1. Multiple cloning site (MCS) 
pGEX-KG: 
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pCMVMCS: 
 
 
2.4.2. Generated constructs 
Name Insert Template Vector Enzyme 
template/ vector 
Topo constructs     
pCDNA 3.1 TOPO 
Liprin-α1 
Liprin-α1 
(mouse) cDNA 
pcDNA 3.1-
TOPO - 
pCDNA 3.1 TOPO 
Liprin-α2 
Liprin-α2 
(mouse) cDNA 
pcDNA 3.1-
TOPO - 
pCDNA 3.1 TOPO 
Liprin-α3 
Liprin-α3 
(mouse) cDNA 
pcDNA 3.1-
TOPO - 
pCDNA 3.1 TOPO 
Liprin-α4a 
Liprin-α4 
(mouse) cDNA 
pcDNA 3.1-
TOPO - 
pCDNA 3.1 TOPO 
Liprin-α4b 
Liprin-α4 
(mouse) cDNA 
pcDNA 3.1-
TOPO - 
pCMV N-term. GFP 
Liprin-α2 
Liprin-α2 
(mouse) 
pCDNA 3.1 
TOPO Liprin-α2 
pCMV N-term. 
GFP 
BglII-PacI/ 
BamHI-PacI 
pCDNA N-term. GFP 
Liprin-α1a Liprin-a1a 
pCDNA 3.1 
TOPO Liprin-α1 
pcDNA6.2 N-
termGFP 
TOPO 
- 
pCDNA N-term. GFP 
Liprin-α1b C-term. 
Liprin-a1b 
C-term. cDNA 
NT-GFP 
Fusion TOPO 
TA 
- 
pCDNA N-term. GFP 
Liprin-α4b Liprin-a4b 
pCDNA 3.1 
TOPO Liprin-
α4b 
pcDNA6.2 N-
termGFP 
TOPO 
- 
Vectors     
pCMV MSC Oligo Oligo pCMV5 -/EcoRI-BamHI 
PCMVMCS GFP N-
term. EGFP EGFP pCMVMCS KpnI 
pCMV MSC HA HA tag HA oligo pCMVMCS -/KpnI 
PCMVMCS paGFP N-
term. paGFP paGFP pCMVMCS KpnI 
GFP fusion 
constructs     
pCMV N-term. GFP 
Liprin-α2 
Liprin-α2 
(mouse) 
pCDNA 3.1 
TOPO Liprin-α2 
pCMV N-term. 
GFP 
BglII-PacI/ 
BamHI-PacI 
pCMV N-term. GFP 
Liprin-α2 sdm sdm RBD 
pCMV N-term. 
GFP Liprin-α2 - - 
pCMVMCS N-term. 
GFP Liprin-α2 N-term. 
half 
Liprin-α2 
N-term. 
half 
pCDNA 3.1 
TOPO Liprin-α2 
pCMVMCS N-
term. GFP 
BglII-PacI/ 
BamHI-PacI 
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Name Insert Template Vector Enzyme 
template/ vector 
pCMVMCS N-term. 
GFP Liprin-α2 C-term. 
half 
Liprin-α2 
C-term. 
half 
pCDNA 3.1 
TOPO Liprin-α2 
pCMVMCS N-
term. GFP 
BglII-PacI/ 
BamHI-PacI 
pCMVMCS N-term. 
GFP Liprin-α3 CC 
domain  
Liprin-α3 
CC 
domain 
pCDNA 3.1 
TOPO Liprin-α3 
pCMVMCS N-
term. GFP 
BglII-PacI/ 
BamHI-PacI 
HA fusion 
constructs     
pCMVHA Liprin-α2 
RBD 
Liprin-α2 
RBD 
pCDNA 3.1 
TOPO Liprin-α2 pCMVHA 
BglII-PacI/ 
BamHI-PacI 
pCMVHA RIM1α C2B RIM1α 
C2B 
pCMV YFP-
RIM1α pCMVHA 
BglII-PacI/ 
BamHI-PacI 
pCMVHA RIM1α 
C2Bsdm1 
RIM1α 
C2Bsdm1 
pCMV GFP-
RIM1α sdm1 pCMVHA 
BglII-PacI/ 
BamHI-PacI 
pCMVHA RIM1α 
C2Bsdm2 
RIM1α 
C2Bsdm2 
pCMV GFP-
RIM1α sdm2 pCMVHA 
BglII-PacI/ 
BamHI-PacI 
fl RIM1α constructs     
pCMV-cherry RIM1α   cherry cherry pCMV RIM1α ERI/XhoI 
pCMV-GFP RIM1α  GFP GFP pCMV RIM1α ERI/XhoI 
pCMV-paGFP RIM1α paGFP paGFP pCMV RIM1α ERI/XhoI 
pCMV GFP-RIM1α 
sdm1 sdm 
pCMV-GFP 
RIM1α - - 
pCMV GFP-RIM1α 
sdm2 sdm 
pCMV-GFP 
RIM1α - - 
pGEX constructs     
pGEX Liprin-α1 peptid oligo - pGEX BamHI/HindIII 
pGEX Liprin-α2 peptid oligo - pGEX BamHI/HindIII 
pGEX Liprin-α3 peptid oligo - pGEX BamHI/HindIII 
pGEX Liprin-α4 peptid oligo - pGEX BamHI/HindIII 
pGEX Liprin-α2 RBD RBD pCMV N-term. GFP Liprin-α2 pGEX BamHI/HindIII 
pGEX Liprin-α2 
RBDsdm RBDsmd 
pCMV N-term. 
GFP Liprin-α2 
sdm 
pGEX BamHI/HindIII 
shRNA constructs     
pAMU6-
Liprinα1shRNA 1469 Oligo - pAMU6 
BamHI-HindIII/ 
BglII-HindIII 
pAMU6 
Liprinα2shRNA 1468 Oligo - pAMU6 
BamHI-HindIII/ 
BglII-HindIII 
pAMU6 
Liprinα2shRNA 1652 Oligo - pAMU6 
BamHI-HindIII/ 
BglII- HindIII 
pAMU6 
Liprinα2shRNA 1654 Oligo - pAMU6 
BamHI-HindIII/ 
BglII-HindIII 
pAMU6 
Liprinα2shRNA 1656 Oligo - pAMU6 
BamHI-HindIII/ 
BglII-HindIII 
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Name Insert Template Vector Enzyme 
template/ vector 
pAMU6 
Liprinα2shRNA 1658 Oligo - pAMU6 
BamHI-HindIII/ 
BglII-HindIII 
pAMU6 
Liprinα3shRNA 1642 Oligo - pAMU6 
BamHI-HindIII/ 
BglII-HindIII 
pAMU6 
Liprinα3shRNA 1644 Oligo - pAMU6 
BamHI-HindIII/ 
BglII-HindIII 
pAMU6 
Liprinα3shRNA 1646 Oligo - pAMU6 
BamHI-HindIII/ 
BglII-HindIII 
Table 3.12: List of all constructs 
 
Plasmids obtained from other labs: 
pGEX GRIP (aa343-809) construct: Prof. H. Hirling (Geneva, Switzerland) 
pCMV YFP-RIM1α, pCMV RIM1α: Gyorgy Lonart (EVMS, Norfolk, USA) 
SV2cherry: Noam Ziv (Haifa, Israel) 
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3 Methods 
All methods were performed following standard procedures (Current Protocols in 
Molecular Biology) if not noted otherwise. 
3.1 Bioinformatics 
3.1.1. Sequence analysis 
The National Center for Biotechnology Information (NCBI) (http://www.nlm.nih.gov/), 
the ENSEMBL (http://www.ensembl.org/), UCSC (http://genome.ucsc.edu/index.html) 
and the TIGR gene indices (http://www.tig.org/) databases were searched using 
homology BLAST with standard settings. Searches for splice variants were 
conducted using EST databases. Multiple alignments were performed using T-coffee 
(http://tcoffee.vital-it.ch/cgibin/Tcoffee/tcoffee_cgi/index.cgi), ClustalW 
(http://www.ebi.ac.uk.clustalw/index.html) and Dialign (http://bibiserv.techfak.uni-
bielefeld.de/dialign/) (Morgenstern, 2004). Boxshade was used to create alignment 
figures (http://bioweb.pasteur.fr/seqanal/interfaces/boxshade.html). Phylogenetic 
analyses were conducted with Phyml Online (http://atgc.lirmm.fr/phyml/) using 
standard settings with 100 bootstraps and the WAG substitution model for sequence 
evolution (Whelan and Goldman, 2001). 
Sequence data for the cDNA sequences of Liprins-α was deposited with the 
DDBJ/EMBL/GenBank Data Libraries under Accession No. EU568869 (Liprin-α1), 
EU568870 (Liprin-α2), EU568871 (Liprin-α3), EU568872 (Liprin-α4). 
3.2 Molecular biological methods 
3.2.1. RNA extraction and cDNA synthesis 
Total RNA was extracted from whole brains of different developmental stages, 
various tissues, and brain regions using the RNeasy Lipid Tissue Kit following 
manufacturers instructions. Samples were stored at -80°C. Reverse transcription was 
carried out using 5µg of total RNA and the Superscript RT III kit with oligo dT primers 
for full length cloning of Liprins-α. 1µg of total RNA and the iScript cDNA synthesis kit 
were used as template for PCR reactions to detect alternative spliced exons. For 
real-time PCR the QuantiTect reverse transcription kit was employed, using 1 µg 
RNA. cDNA samples were stored at -20°C. 
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3.2.2. PCR 
Standard PCR protocol: 
 
Step Temperatur time  cycle 
1 95°C  4 min 
2 95°C  30 sec 
3 55°C  45 sec  
4 72°C  xkb x 1min 35 cycles step 2-4 
9 4°C  ∞ 
 
 
Touch down PCR protocol: 
 
Step Temperatur time  cycle 
1 95°C  4 min 
2 95°C  30 sec 
3 67°C  30 sec -0.5°C every cycle 
4 72°C  8 min  20 cycles step 2-4 
5 95°C  30 sec 
6 50°C   30 sec 
7 72°C  8 min  15 cycles step 5-7 
8 72°C  10 min 
9 4°C  ∞ 
 
General amplification procedure: 
For all amplifications from plasmid DNA pfu DNA polymerase and the standard PCR 
protocol were used, except for the full-length amplification of Liprin-α2, for which a 
touch down PCR was performed. 
 
Detection of alternative splicing: 
Alternative splicing of exons was detected via PCR using Taq polymerase (GoTaq). 
PCR conditions were optimized for each primer pair and the resulting fragments were 
analyzed on 2.5% agarose gels and visualized by ethidium bromid staining. Several 
independent primer pairs were used to analyze each alternatively spliced exon. 
Primers used in the analysis are listed in table 3.7.  
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Amplification of full length Liprins-α from cDNA: 
Full length Liprin-α1-4 were amplified using the Fermentas Long PCR Enzyme Mix. 
Primers used for the amplification are listed in table 3.3. Standard conditions were 
used and 2.5% DMSO was added to the PCR mix.  
3.2.3. Real-time PCR 
Validated real-time PCR primer pairs for Liprins-α1-4 were purchased from Qiagen 
QT01594712 (Liprin-α1), QT01616839 (Liprin-α2), QT01577415 (Liprin-α3), 
QT01596756 (Liprin-α4). Real-time PCR was performed using the SYBR Green PCR 
kit following the manufacturers instructions. Each sample was assayed in triplicates 
and in two independent experiments using an ABI Prism 9700HT sequence detection 
system. Relative quantification of target gene expression and PCR efficiency were 
performed using HPRT as internal reference genes. The expression levels of the 
genes was calculated using the formula (ProbeCT) − (ActinCT) = z; Probeexpr = 2− 
z. 
3.2.4. Vector construction 
For cloning DNA fragments were amplified from plasmid DNA via PCR, purified (DNA 
Clean and Concentration kit) and cut with the respective restriction enzymes. 
Subsequently, the PCR reaction was separated on an agarose gel and the band of 
interest was cut out and purified (Zymoclean Gel DNA recovery kit). The vector was 
cut with the respective restriction enzymes, dephosphorylated and then purified with 
phenol-chloroform followed by precipitation of the DNA. Then the ligation reaction 
was carried out at 37°C for 1 h.  
3.2.5. Site directed mutagenesis 
Primers were designed with the help of the QuickChange Primer Designe Program 
(http//www.stratagen.com/qcprimerdesign). Mutations were introduced using the 
QuickChange II XL Site-Directed Mutagenesis Kit using standard conditions as 
recommended by the manufacturer. For introduction of point mutations into Liprin-α2 
a touch down PCR was performed. 
3.2.6. Sequencing 
The PCR reaction for sequencing of plasmid DNA was performed using the BigDye 
Terminator v3.1 cycle sequencing kit and template specific primers (Table 3.9). The 
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sequencing PCR reactions were purified through a gel filtration spin column (DyEx 
2.0 spin kit) and sequencing was carried out using a capillary sequencer. 
Subsequent analysis of the sequencing results was carried out using Lasergene 8 
software SeqMan. 
3.3 Biochemical methods 
3.3.1. Peptid-antibody generation 
Specific antibodies against Liprin-α1 (α1), Liprin-α2 (α2), Liprin-α3 (α3), and Liprin-
α4 (α4) were raised in rabbits against the following peptides: (α1) 
CSHGSGSPSQPDADSHFE; (α2) SSYHNDARSSLSAC; (α3) 
RGRPPSSYSRSLPGSC; (α4) DPLGPPHGADAEANFEC. A cysteine was added N- 
or C-terminally for coupling. The localization of the peptides is shown in Suppl. Fig. 2. 
Antibodies were affinity purified using the immunizing peptides according to standard 
procedures. Generation and purification was performed by  Pineda  antibody  
service  (http://www.pineda-abservice.de/).   
3.3.2. Western Blotting 
Preperation of protein extracts: 
Tissue was lysed in 1xPBS with 2% SDS, 10mM EDTA pH 8.0 and Complete 
Protease Inhibitor Cocktail Tablets and HEK-293T cells over expressing Liprins-α 
were lysed in PBS with 1% Triton X-100 and Complete Protease Inhibitor Cocktail 
Tablets.  
 
Electrophoreses and blotting: 
5x loading buffer was added to the samples, which were  heated  to  95°C  for  5  
minutes for denaturation. For all immunoblots performed to analyse expression in 
tissues, 50  µg  protein was loaded  on 10% SDS-polyacrylamide gels. Proteins were 
separated by size during electrophoresis  and  subsequently 
transferred to nitrocellulose membrane. Membranes were preincubated for one  hour  
at  room  temperature  (RT)  in  blocking  solution  (2%  cold water fish gelatin or 10% 
milk in PBS),  and  then  incubated  with  the  primary  antibodies  for  1  hour  at  
RT.  Secondary  antibodies  were  IR-labeled  (Odyssey)  and  used  at  a  1:20.000  
dilution or horseradish peroxidase labeled and used at 1:3000.  The  IR-labeled 
secondary antibodies  were  visualized  with  an  infrared  imaging  System  
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(Odyssey, Li-cor) and HRP coupled secondary antibodies were visualized by 
Amersham ECL Plus Western Blotting Detection Reagents using the HyperFilm. 
Quantitative analysis of immunoblots was performed using the AIDA software.  
3.3.3. Protein purification from bacteria 
GST-fusion proteins were overexpressed in Echeria coli BL21. After induction with 
IPTG cultures were grown for 5h at 37°C. For purification bacteria were resuspended 
in PBS containing Complete Protease Inhibitor Cocktail Tablets and lyzed by 
incubation with lysozyme and subsequent sonification. GST-fusion proteins were 
bound to glutathione-agarose beads through incubation for 1h followed by washing. If 
necessary, elution was performed with 10 mM gluthatione in PBS. For analysis, 
proteins were loaded on a SDS-PAGE gel and visualized using Coomassie.  
3.3.4. Pull down assay 
For the pull-down assay, the GST-GRIP, GST-Liprin-α2 RBD (RIM binding domain), 
GST-Liprin-α2 RBD sdm and GST-RIM1α C2B fusion proteins were expressed in 
Echeria coli BL21 and bound to glutathione-agarose beads. Transfection of HEK-
293T cells with the expression plasmids for GFP-Liprin-α1a, GFP-Liprin-α1b C-term., 
Liprin-α4a, GFP-Liprin-α4b, HA-Liprin-α2 RBD, RIM1α C2B, RIM1α C2B sdm1 and 
RIM1α C2B sdm2 were performed with Lipofectamine 2000 (GRIP interactions) or 
Ca2+-phosphate transfection (Liprin-α2-RIM1α interaction). To test binding of the 
alternatively spliced C-terminus of Liprin-α1 and -α4 to GRIP cells were harvested 3 
days after transfection and lysed in buffer L1 (20 mM HEPES/KOH, pH 7.4, 2 mM 
EDTA, 2 mM EGTA, 0.1 mM DTT, 0.1 M KCl, 1% Triton X-100, Complete Protease 
Inhibitor Cocktail Tablets) for 1 h at 4 °C. All other assays were performed in buffer 
L2 (50 mM HEPES, pH 7.4, 80 mM NaCl, 1% Trion X-100, Complete Protease 
Inhibitor Cocktail Tablets). The extracts were subsequently incubated with GST and 
GST- fusion proteins on agarose beads equilibrated in buffer L1/L2 for 3h. After 
washing bound proteins were analyzed by western blotting. Liprin-α1a and -α1b were 
detected with an anti-GFP antibody while Liprin-4αa and -4αb were detected with a 
pan-Liprin-α antibody (4396). HA-tagged proteins were detected by an anti-HA 
antibody. 
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3.4 Cell culture 
3.4.1. HEK-293 cell culture 
HEK-293T and AAV-293 cells were maintained in DMEM, 10% FCS and 
penicillin/streptomycin (100 units/ml penicillin and 100 mg/ml streptavidin). Cells were 
passaged every 2-3 days and plated in a 1:10 dilution. All cell lines were cultured in 
humidified incubators supplied with 5% CO2 at 37°C. 
3.4.2. Transfection of HEK-293 cells 
For heterologous expression human embryonic kidney-293 cells (HEK 293T or AAV-
293) were transfected using Lipofectamine 2000. 
For the overexpression of poteins used in pull down assays to test point mutations 
and their effect on the Liprin-α2-RIM1α interaction 10 cm plates were transfected 
using the Ca2+-phosphate method. Cells were transfected at approximatly 70% 
confluency. Before transfection the medium was exchanged for IMDM containing 5% 
FCS. DNA and CaCl2 were mixed and HBS was added while vortexing. The 
precipitate was directly added to the cells and left to incubate over night. The next 
day the cells were washed one time with PBS and then kept in DMEM with 10% FCS 
and Pen/Strep until they were harvested after three days. 
 
Plasmid  20 µg 
2,5M CaCl2  30 µl 
H2O      x µl   
Σ  300 µl 
+  
1xHBS  300 µl 
 
3.4.3. Primary cell culture  
Solutions: 
• Borate buffer containing 0.1 mg/ml Poly-L-Lysin 
• HBSS containing 20% FCS 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• Digestion solution: 
0.8 g NaCl 
0.037 g KCl 
0.099 g Na2HPO4 
0.6 g Hepes  
in dd H2O  
adjust pH to 7.2  
 
• Dissociation solution: 
100 ml HBSS containing 0.295g MgSO4-7H2O 
 
• BME: 
500 ml BME containing 
1% FCS  
2 % B-27  
1% Glucose  45 % 
1.2 ml L-Glutamine (200mM) 
 
Coverslip and well pretreatment: 
To  allow  optimal  adhesion  of  the  neurons  on  the  coverslips  or  wells  they  were 
pretreated as follows. Coverslips were baked over night at 240 ºC. 24 wells with or 
6  wells  without  sterile  coverslips  were  then  coated  overnight  by  incubation  with 
poly-L-Lysin (0.1 mg/ml in borate buffer) at 37ºC. Wells were subsequently washed 
three  times  with  sterile  distilled  water  and  several  hours  later  two  additional 
washing steps followed. 
 
Preparation of primary neurons: 
The pregnant rat or mouse was sacrificed, and the uterus containing the embryos 
(E16-E19)  was  removed. The  embryo  heads  were  dissected  in  HBSS/20% FCS 
and  placed  in  a  Petri  dish  with  ice-cold  dissection  medium.  The  cortex  and  the 
hippocampus of every pup were  isolated and separately collected  in a Petri dish. 
The cortex was cut in approx. 1 mm thick pieces. The tissue was washed six times 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in  HBSS/20% FCS,  trypsin  solution  (3mg  trypsin  in  0.5  ml  digestion  solution  per 
pup) was added  to  the  tissue and both were  transferred  into  a  3.5 mm dish  and 
incubated  for  10 minutes  at  37  ºC. The  tissue was  then  transferred  into  a  15  ml 
Falcon  tube  and  washed  three  times  with  HBSS/20%  FCS.  The  tissue  was 
resuspended in 2 ml dissociation solution by repetitive tituration (20-50 x) using a 
blue tip. 3 ml HBSS/20% FCS were added and the solution was centrifuged for 10 
min at 1000 rpm.  
The supernatant was transferred into a new Falcon tube and 2 ml BME were added. 
Tituration  was  repeated.  Per  pup  2  ml  BME  medium  is  added,  the  cells  were 
counted using a Neubauer chamber and seeded (see table below). After two hours 
the medium was replaced with fresh BME. 
Cells were kept at 37°C and 5% CO2 for up to four weeks. Once a week half of the 
BME per well was exchanged for fresh medium.  
Cell numbers seeded: 
 
 
 
 
3.4.4. Transfection of neurons 
Primary cortical and hippocampal neurons were transfected using a protocol for 
hippocampal neurons based on DNA/Ca2+-phosphate coprecipitation as descibed by 
Kohrmann et al. (Kohrmann et al., 1999). Neurons were transiently transfected at 
DIV3-10. The original culture medium was exchanged for MEM and kept in the 
incubator for the time of the transfection procedure. Per 24 well 1.5 µg endotoxin free 
DNA were used. CaCl2, DNA and BES buffer were vortexed for 20 sec. Then the 
precipitate was added to the neurons and incubated at 2.5% CO2 for 30-40 min. 
Subsequently, cells were washed twice with HBS and three times with BME and then 
the original medium was added back to the wells.  
Well Cell number 
24 well (low density) 30.000 
24 well (high density) 60.000 
6 well (high density) 300.000 
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3.5 Immunochemical methods 
3.5.1. Immunocytochemistry 
Primary cortical and hippocampal neurons DIV4 and DIV14-21 as well as glial cells 
DIV21 were fixed with 4% paraformaldehyde (PFA) for 15 min, washed in PBS and 
incubated over night with primary antibodies at 4°C in blocking solution 1 (10% 
normal goat serum, 5% sucrose, 0.2% BSA, 0.3% Triton X-100 in PBS). After 
washing in PBS, cells were incubated with secondary antibodies in blocking solution 
2 (5% sucrose, 0.3% Triton X-100, 0.2% BSA in PBS) at room temperature in the 
dark. Cover glasses were mounted in Mowiol. 
3.5.2. Immunohistochemistry 
Freshly dissected brain regions and retinae were immersion fixed in 4% PFA for 15-
30 min. Tissue was cryoprotected by immersion in increasing concentrations of 
sucrose in PBS (10%, 20%, 30%) at 4°C and subsequently embedded in freezing 
medium (Tissue-Tek). 12 µm (brain) and 16 µm (retina) sections were cut on a 
microtome (Microm). The sections were blocked for 1 hour in blocking solution (10% 
normal goat serum, 0.5% Triton X-100 in PBS) and incubated in the primary 
antibodies in 3% normal goat serum, 0.5% Triton X-100 in PBS) over night at room 
temperature. After extensive washing in PBS, sections were incubated with 
secondary antibodies coupled to Alexa594 or Cy3 and Alexa488 for 1 hour at room 
temperature in the dark. Slices were mounted in Vectashield hard set mounting 
medium. 
3.6 Imaging 
3.6.1. Light microscopy 
For light microscopic analysis labeled sections were imaged with a fluorescent 
microscope (Zeiss Axio Observer 1A). For high magnification cells and sections were 
examined with a confocal laser scanning microscope (Leica TCS and Zeiss 
LSM710).  
3.6.2. Time lapse imaging 
FRAP and FRAPA time lapse imaging experiments were performed as described in 
(Tsuriel et al., 2006; Tsuriel et al., 2009). 
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Neurons expressing the fusion proteins were placed in a laminar flow chamber and 
maintained at 33–35°C in a physiological solution. After collecting baseline images, 
three to five fluorescent puncta per axon area, using multiple axonal areas per 
experiment, were selectively bleached by high-intensity 488 nm laser light for FRAP 
experiments or phoptactivated by a 405 nm diode laser for FRAPA experiments. 
Fluorescence recovery was monitored by collecting image stacks (two to three 
sections) at rates of one image every 10 min for 2-16 h for FRAP experiments and at 
rates of one image every 1 h for FRAPA experiments.  
3.7 rAAV virus  
3.7.1. rAAV virus production 
For rAAV virus production AAV-293 cells were seeded onto 10 cm plates and 
transfected at ca. 70% confluency using the Ca2+-phosphate transfection method. 
Before transfection the medium was exchanged for IMDM containing 5% FCS. DNA 
and CaCl2 are mixed and HBS was added while vortexing. The precipitate was 
directly added to the cells and left to incubate over night. The next day the cells were 
washed one time with PBS and then kept in DMEM with 10% FCS and Pen/Strep 
until harvested after three days. The cells were harvested in 1 ml DMEM and frozen 
at -80°C. To disrupt the cell walls harvested cells were thawed and frozen for four 
times. To investigate the efficiency of the crude extract containing viral particles 1µl, 
0.1µ and 0.01µl were tested on a 24 well of primary neurons.  
 
Plasmid  6.6 µg 
PFdelta6          13.3 µg 
pNLrep  3.2 µg 
pH21  3.3 µg 
2,5M CaCl2  176 µl 
H2O      x µl   
Σ           1600 µl 
+  
1xHBS    1600 µl 
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3.7.2. shRNA experiments using rAAV viruses 
The rAAV virus system was used to transduce neurons with plasmids containing 
shRNAs. To get the most effective knock-down the virus was added to the primary 
neurons on DIV1-2. To evaluate the knock down 6-wells were used for western 
blotting and 24-wells were used for immunocytochemistry. For immunoblotting 
neurons were checked for transduction efficiency at DIV7 and if 100% transduction 
was achieved the cells were harvested at DIV14. For immunocytochemistry a dilution 
of the virus that allowed the transduction of only a few cells was determined. Neurons 
were fixed and immunostained at DIV14. 
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4 Abbreviations 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
APC  Anaphase promoting complex       
AZ Active zone 
CaMKII  Ca2+/calmodulin-dependent protein kinase II 
CASK  Calcium/calmodulin-dependent serine protein kinase 
DG Dentate gyrus 
ELKS Name stems from the proteins high content in glutamate (E), leucine 
(L), lysine (K), and serine (S) 
EM Elektron micropgraph  
FRAP  Fluorescent recovery after photobleaching 
FRAPA  Fluorescent recovery after photoactivation 
GC   Cerebellar  granule  cell  layer  
GFP      Green  fluorescent  protein   
GIT1     G  protein-coupled  receptor  kinase-interacting  protein  1   
GRIP1     Glutamate  receptor-interacting  protein  1   
h       Hour    
HBS  HEPES buffered saline 
HBSS  Hanks buffered salt solution 
HC       Hippocampus   
HEK 293T  Human embryonic kidney cell line 293T 
ICC      Immunocytochemistry 
IHC      Immunohistochemistry 
INL      Inner nuclear layer 
IPL      Inner plexiform layer 
IR       Infrared      
Kb       Kilo  base   
kDa      Kilo  Dalton   
KIF1A     Kinesin  family  member  1A   
l        Liter   
LAR      Leukocyte  common  antigen-related     
LH       Liprin  homology  domain   
MAGUK  Membrane-associated guanylate kinase 
MCS     Multiple cloning site 
min      Minute 
ML       Molecular layer   
ml       Mililiter  
mM      Milimolar   
mRNA     Messenger  RNA    
ng    Nanogram 
NGS               Normal goat serum 
NMJ     Neuro muscular  junction   
OB       Olfactory  bulb   
Oligo     Oligonucleotide 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OPL     Outer plexiform layer 
paGFP    photoactivatable GFP 
PL      Polymorphic layer 
P0      Postnatal day  0 
PAGE     Polyacrylamide gel electrophoresis   
PBS      Phosphate  buffered  saline   
PC       Purkinje  cells   
PCR      Polymerase  chain  reaction   
PDZ      PDZ-protein binding domain   
PFA      Paraformaldehyde   
PKA      Protein kinase  A   
PSD     Postsynaptic density   
RIM      Rab  interacting  molecule     
RNA     Ribonucleic  acid   
RT       Room  temperature   
RT-PCR     Reverse  transcription  PCR   
RSY-1  regulator of synaptogenesis-1 
SAM      Sterile-α-motif      
SDS      Sodium dodecyl sulfate   
SL      Stratum lucidum 
SM      Stratum moleculare 
SP      Stratum pyramidale 
SV       Synaptic  vesicle   
SV2      Synaptic  vesicle  protein  2   
SYD-1    synapse- defective 1 
SYD-2    synapse- defective 2 
μl          Microliter  
WB      Wester blot 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5 Results 
5.1 Analysis of the genomic organization of the mouse and 
human Liprin-α  family and their alternative splicing 
Liprins-α exhibit a striking degree of conservation, with 40% amino acid identity 
between the human Liprin-α1 and worm SYD-2. All Liprin-α proteins share a 
common domain organization as they are composed of an N-terminal region 
predicted to form coiled-coil structures and three C-terminal SAM (sterile-α-motif) 
domains that constitute the LH (Liprin homology) region (Pulido et al., 1995; Serra-
Pages et al., 1995; Serra-Pages et al., 1998). Recent studies have begun to shed 
light on the neuronal functions of Liprins-α (Spangler and Hoogenraad, 2007; Stryker 
and Johnson, 2007a) and have provided first evidence for potential functional 
differences between the four isoforms (Hoogenraad et al., 2007). However, so far the 
sequence, structures, and alternative splicing of Liprin-α genes have not been 
comparatively and thoroughly analyzed. 
5.1.1. The structure of human and mouse Liprin-α genes 
We characterized the exon/intron structure of human and mouse Liprin-α genes and 
analyzed the alternative splicing pattern of each Liprin-α gene in both human and 
mouse using bioinformatics and RT-PCR. For each Liprin-α a search for mRNA 
sequences and expressed sequence tags (ESTs) was performed. Furthermore, the 
identified cDNAs of mouse were cloned and verified by sequencing. 
The properties of the human and mouse Liprin-α genes are summarized in Table 5.1, 
the genomic structure of the human and mouse genes is depicted in Fig. 5.1, and the 
sizes of the exons and the sequences of the exon-intron junctions are shown in 
Suppl. Tables 1-8. The four Liprin-α genes are dispersed in the human and mouse 
genome, but exhibit highly conserved exon-intron structures, suggesting that they are 
the result of a relatively recent gene duplication. The number of exons differs 
between the Liprins-α, due to additional exons as well as distinct numbers of 
alternatively spliced exons. The individual genes are highly conserved between the 
mouse and human genomes with mostly identical placement of the exons and sizes 
of the introns (Fig. 5.1).  
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Fig. 5.1: Comparison of the human and mouse Liprin-α  gene structures.  
The organization of the exon/intron structure for the individual human and mouse 
Liprin-α1, Liprin-α2, Liprin-α3, and Liprin-α4 genes was determined by bioinformatic 
analysis of genomic and mRNA data bases and by RT-PCR. Exons are represented 
by numbered solid boxes. An arrow above an exon indicates the start of translation 
and a dot marks a stop codon. Alternatively spliced exons are labeled with an 
asterisk. The rulers above each gene diagram depict the positions in the USCD 
genome sequences. 
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The human and mouse Liprin-α2 genes are large with sizes of approximately 500 kb, 
while the Liprin-α3 and Liprin-α4 genes are relatively small, approximately 30 kb and 
40 kb, respectively (Table 5.1, Fig. 5.1). The human and mouse Liprin-α1 genes are 
of intermediate size, 114 kb (human) and 77 kb (mouse). It is notable that in Liprin-α1 
and Liprin-α2 the exon containing the translation start site is separated from the 
remaining clustered exons by a large intron, around half the size of the complete 
genes. In the case of Liprin-α2 this intron contains an additional exon (Exon 3), which 
is not present in any of the other Liprin-α genes. 
Tabel 5.1: Chromosomal locations and sizes of Liprin-α genes 
 
5.1.2. Liprin-α genes in human and mouse display distinct alternative splicing 
Even though the overall gene structure of the Liprin-α genes is highly conserved, 
database analysis and RT-PCR revealed striking variations in alternative splice 
patterns among the four Liprin-α isoforms and between human and mouse orthologs. 
Liprin-α1, composed of 32 exons in human and mouse, is the family member with the 
highest degree of alternative splicing (Suppl. Table 9 and 10). We identified 5 
alternatively spliced cassette exons (exons 10, 18, 24, 25, and 31) in the human and 
mouse genes encoding Liprin-α1. Exon 10 is only found in Liprin-α1 and is inserted 
within the ELKS binding regions (Ko et al., 2003a). In contrast, exons 18, 24, and 25 
are located between characterized domains: the only ten amino acids encompassing 
exon 18 between the coiled-coil region and the first SAM-domain and the small 
exons 24 and 25, with a size of 22 and 10 amino acids, respectively, between the 
first and second SAM-domain (Fig. 5.2). Moreover, in human and mouse, exon 26 
includes an alternative splice acceptor site, leading to the deletion or insertion of a 
short 3-residue sequence (Suppl. Tables 1, 2). The human Liprin-α1 gene contains 
an alternative splice donor site for exon 30 that is not found in the rat or mouse 
genome. The use of this site results in an exon with an in-frame stop codon (Fig. 
5.3A).  
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Fig. 5.2: Protein domain and exon-intron structure of mouse Liprins-α1-4.  
The sequence alignment of mouse Liprins-α1-4 shows their highly similar overall 
organization and high sequence conservation. Black boxes indicate identical amino acid 
residues and grey boxes similar residues. Protein interaction domains are underlined: red, 
RIM interaction domain; blue, ELKS interaction domain; green, GIT interaction domain; 
yellow, the three SAM-domains. Light blue arrows mark conserved exon borders and light 
blue lines indicate diverging exon borders. Alternatively spliced exons are highlighted by 
orange boxes.  
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The encoded protein does not contain the conserved C-terminal PDZ-binding motif 
through which Liprins-α interact with GRIP (Wyszynski et al., 2002). The exclusion of 
cassette exon 31, which is found in the human and mouse genome, also generates a 
transcript coding for a protein without the C-terminal PDZ-binding motif (Fig. 5.3A, 
Suppl. Tables 1, 2). Therefore, alternative splicing of the C-terminal exons results in 
Liprin-α1 proteins with three (human) or two (mouse) distinct C-termini (Fig. 5.3, Fig. 
5.4A).  
 
Fig. 5.3: Liprins-α  share the same modular organization but are diversified via 
alternative splicing. 
(A), The cartoon shows the conserved modular organization of Liprins-α1-4. Alternative 
splicing of Liprin-α1 and -α4 results in variants with diverging C-termini. The alignment was 
performed using the mouse Liprin-α sequences. Variants Liprin-α1a and -α4a contain the 
conserved PDZ-interaction motif, whereas this motif is absent in the variants Liprin-α1b and -
α4b. The arrow and line labels the last exon boarder. Sequences were aligned using T-
coffee. Boxshade was used to create the alignment figure. Black boxes indicate identical 
amino acid residues and grey marks similar residues. CC, coiled-coil domains, S, SAM 
domains. (B), Characterization of the interaction of GRIP1 with the different C-terminal 
variants of Liprin-α1 and 4. HEK-293T cell lysates transiently transfected with C-terminal 
variants of Liprin-α1 and -α4 were pulled down by GST-GRIP-PDZ6 or GST, and analyzed 
by immunoblotting with antibodies against GFP or pan-Liprin-α. Only the a variants, which 
contain the consensus PDZ-binding motif (-VRTYSC) specifically bind to GST-GRIP. 
A 
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Fig. 5.4: Alternative Splicing is regulated during development.  
(A), Mouse and human orthologs of Liprins-α exhibit diverging alternatively spliced exons. 
The diagram depicts the potential splice patterns for the mouse and human Liprins-α 
orthologs. Exons are represented by numbered grey boxes. (B), RT-PCR analysis of 
alternatively spliced transcripts of mouse Liprin-α1, -α2, and -α4 at different time points 
during development. E12, prenatal day 12; P0, day of birth; AD, adult. Primers flanking the 
exon of interest were used for the RT-PCR and the resulting fragments were resolved on an 
agarose gel. cDNA was transcribed from mouse whole brain total RNA. A DNA size marker 
is indicated at the left. The upper band corresponds to the PCR product including the 
examined exon, whereas the lower band (marked by a Δ) represents the product without the 
exon. 
A 
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The gene encoding Liprin-α2 consists of 32 exons in both human and mouse 
genomes (Suppl. Tables 3, 4). Alternative splicing occurs for exon 6 in human and 
mouse, leading to the presence or the lack of a sequence in the transcript 
immediately downstream the RIM-interaction domain (Fig. 5.2). Analysis of human 
transcripts revealed additional splice variants where exon 23 and 24, which are 
localized in the linker region between the first and second SAM-domains, were either 
present or absent in combination or independently (Fig. 5.4A, Suppl. Table 9). All 
mouse transcripts observed in extensive searches of databases and by RT-PCR of 
various mouse mRNAs contained exon 23 and 24 (Fig. 5.4A, Suppl. Table 10). 
Exons 9, 20, and 26 of the mouse Liprin-α2 gene contain alternative splice acceptor 
sites resulting in the insertion or deletion of 1, 4, or 6 amino acids, respectively 
(Suppl. Tables 3, 4). The human and mouse genes that encode Liprin-α3 comprise 
30 exons (Suppl. Tables 5, 6). After comparison of genomic and cDNA sequences, 
alternative splicing was only identified upstream of the second SAM-domain for exon 
23 (Suppl. Tables 9 and 10, Fig. 2).  
Liprin-α4 is encoded by 30 exons in humans and by 29 exons in mice (Suppl. Tables 
7, 8). The difference in exon number between human and mouse Liprin-α4 orthologs 
is due to human exon 11, which is not found in the mouse and rat genome. 
Alternative exon usage generates six human and four mouse Liprin-α4 transcripts. As 
in the other Liprins-α, except Liprin-α2, splicing occurs directly upstream of the 
second SAM-domain, where exon 22 either is included or deleted (Fig. 5.2, Fig. 5.4A, 
Suppl. Tables 9 and 10). Interestingly, we identified a novel C-terminal exon of Liprin-
α4 including an in-frame stop codon. Insertion of this exon (29 in human or 28 in 
mouse) results in Liprin-α4 transcripts , which code for a protein that contains the C-
terminal PDZ-binding motif present in the remaining Liprins−α. The non-conserved C-
terminal sequence (-MLSAFRD) is generated by transcripts missing exon 29 or 28, in 
human or mouse respectively (Fig. 5.3A, 5.4). Liprin-α1 and Liprin-α4 variants 
without the conserved VRTYSC C-terminal sequence are predicted to not interact 
with the adaptor protein GRIP. To test this hypothesis we performed GST pull-down 
assays using GST-GRIP (aa343-809) and HEK-293T cell lysates transfected with the 
variants of mouse Liprin-α1 and Liprin-α4 (Fig. 5.3B). GST-GRIP, but not GST alone, 
selectively pulled down Liprin-α1a and Liprin-α4a, the variants which contain the 
PDZ-binding motif, but not Liprin-α1b (-VYPHYFYR) and Liprin-α4b (-MLSAFRD) 
(Fig. 5.3B).  
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In summary, it is notable that alternative splicing of Liprin-α4 as is the case for Liprin-
α1 can lead to proteins with diverging C-termini and thereby to the deletion or 
insertion of a protein interaction motif.  
5.1.3. Alternative splicing of Liprins-α is regulated developmentally 
To determine if alternative splice events of the mouse Liprin-α genes are regulated in 
a developmental- or region-specific manner we designed primers to detect the 
alternate transcripts and performed RT-PCR analyses (Fig. 5.4B, Suppl. Tables 9 
and 10). The results showed that mouse Liprin-α alternative transcripts are 
expressed ubiquitously throughout the brain (data not shown). However, most 
alternatively spliced exons of Liprin-α mRNAs exhibited a developmental regulation 
(Fig. 5.4B). The Liprin-α1 transcripts including exon 10 can only be detected in 
mRNA of adult brain. Whereas transcripts lacking Liprin-α1 exon 18 are more 
abundant at E 12.5, this ratio reverses at P0 through adulthood. Liprin-α1 transcripts 
containing exons 24 and 25 are barely detectable at E 12.5 but are strongly 
expressed in the adult brain. In the case of Liprin-α4 the splice variant in which exon 
22 is absent is only found early in development. Interestingly, the novel C-terminal 
Liprin-α4 exon 28 is only found at high levels in the adult mouse brain. 
5.1.4. Liprin-α proteins are highly evolutionary conserved 
A phylogenetic comparison of human and mouse Liprin-α full-length sequences 
classifies Liprin-α2 and -α4 as more closely related to each other than to Liprin-α1 
and Liprin-α3, which is the most distant family member (Fig. 5.5A). While in 
invertebrates there is only one Liprin-α, starting in the clade of the Euteleostomes as 
early as in the Danio rerio four Liprins-α are found. All Liprin-α proteins share a 
common domain structure with a N-terminal coiled-coil region, three C-terminal SAM-
domains and a conserved seven amino acid sequence at the C-terminus, which 
functions as a PDZ interaction motif. The four human and mouse family members 
share an extremely high degree of amino acid identity, ranging for the full-length 
proteins from 58%-66%. Their significant overall conservation with regard to amino 
acid identity and similarity is apparent in the alignment of their sequences (Fig. 5.2 
and Suppl. Fig 1). In addition, this alignment highlights the striking similarity of the 
three C-terminal SAM-domains and their conserved PDZ interaction motif at the C-
terminus. Surprisingly, whereas the Liprin-α SAM-domains not only exhibit a 
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remarkable conservation between the family members but also across species (the 
first SAM-domain of mouse Liprin-α2 is approximately 96% similar to C. elegans 
SYD-2 and 97% to Drosophila Dliprin), the PDZ interaction motif is not present in the 
C. elegans and Drosophila Liprin-α homologs (Fig. 5.5B and Suppl. Fig. 1).  
 
Fig. 5.5: Evolution of the Liprin-α gene family.  
(A), The phylogenetic tree was generated based on a T-coffee alignment of the appropriate 
sequences using PhyML online (http://atgc.lirmm.fr/phyml/). Branch lengths are proportional 
to the amount of inferred evolutionary changes. (B), Liprin-α structural domains are highly 
conserved from C. elegans to human as shown here by an alignment of the first SAM domain 
of C. elegans SYD-2, Drosophila Dliprin and mouse Liprins-α1-4. Sequences were aligned 
using T-coffee. Boxshade was used to create the alignment figure. Black boxes indicate 
identical amino acid residues and grey marks similar residues. 
A 
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Comparison of Liprin-α proteins from C. elegans, Drosophila and mouse furthermore 
identifies a region of very high conservation in the N-terminus of the proteins, 
upstream of the RIM binding domain (Suppl. Fig. 1). This sequence constitutes the 
beginning of a predicted coiled-coil region and does not exhibit any significant 
homology with any other protein in the databases (the closest match is the myosin 
heavy chain 10 with less than 30% identity). The Liprin-α binding sites for RIM, 
ELKS, and GIT have been mapped within the coiled-coil region (Ko et al., 2003a). 
Surprisingly, the interaction domains for RIM and ELKS do not exhibit the high 
degree of homology observed for large parts of Liprin-α proteins but are rather 
composed of a highly conserved sequence stretch and an area of low conservation 
(Fig. 5.2). 
5.2 Analysis of the cellular and subcellular expression pattern of 
Liprin-α1-4 
The bioinformatic analysis revealed a strong evolutionary conservation and striking 
sequence homology of the Liprins-α but also differences in alternative splicing that 
can translate into functional differences by influencing protein interactions. In 
addition, recent evidence from other studies suggests that despite their structural 
conservation the mammalian Liprin-α isoforms are differentially regulated, implying 
that they might exert diverging next to common functions (Hoogenraad et al., 2007). 
A distinct regional and/or subcellular localization could point to further diverging 
functions within the Liprin-α family.  
5.2.1. Expression of Liprin-α transcripts 
To access the expression pattern of the four Liprin-α isoforms on the mRNA level we 
performed quantitative real-time PCR using rat cDNA of different brain regions and 
adult organs and specific primer sets. These had been previously evaluated for their 
specificity because of the high degree of sequence homology between the four 
Liprin-α isoforms. Liprin-α2 and Liprin-α3 are synthesized at high levels in the brain 
and are only found at low levels in other tissues (Fig. 5.6A).  
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Fig. 5.6: Relative expression profiles of rat Liprin-α1-4 in different tissues and 
brain regions of the adult rat.  
(A), Expression of Liprins-α1-4 in selected tissues analyzed by quantitative real-time PCR. 
Bars represent relative mRNA levels normalized to HPRT as internal reference gene. (B), 
Analysis of expression as in (A) in various brain regions. OB, olfactory bulb; STR, striatum; 
CTX, cortex; HC, hippocampus; TH, thalamus; MB, midbrain; CB, cerebellum; BS, brain 
stem. 
 
Liprin-α1 mRNA in contrast was detected ubiquitously, with the lowest level of 
expression in the brain. Liprin-α4 was most prominently expressed in muscle and 
testes but is also present in brain, lung, heart, and thymus; however, the overall level 
of expression was very low. Liprin-α2 and Liprin-α3 exhibited a strong ubiquitous 
expression throughout the brain. Liprin-α2 mRNA levels are highest in the rostral 
brain regions, e.g. the olfactory bulb, striatum, cortex, and hippocampus, and lowest 
in the brain stem, whereas Liprin-α3 is most prominently found in the striatum and 
cortex. Liprin-α1 and Liprin-α4 were also detected in all brain regions analyzed, albeit 
at much lower levels (Fig. 5.6B). Both isoforms were most strongly expressed in the 
cerebellum and only at low levels in the cortex. 
B A 
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5.2.2. Generation of isoform specific antibodies 
To characterize the expression patterns of Liprin-α 1-4 proteins, we raised isoform 
specific antibodies (Suppl. Fig. 2). Due to the strong homology of the four isoforms 
verifing their isoform specificity was critical. Using immunoblotting we could show 
that all antibodies only detected a single isoform, i.e. were isoform specific (Fig. 
5.7).  
 
Fig. 5.7: Characterization of isoform specific antibodies 
(A), Cartoon depicting the modular organization of Liprins-α. CC, coiled coil domain; S, SAM 
(sterile alpha motif) domain. Localization of peptides is indicated. (B), HEK-293T cells were 
transfected with expression constructs encoding full-length mouse Liprin-α1-4. Total cell 
lysates were prepared, and equal lysate fractions were analyzed by immunoblotting. The 
asterisk marks an unspecific signal. (C), Determination of antibody affinity. Defined amounts 
of GST-peptide fusion proteins as well as whole brain lysate (50µg) were analyzed by 
immunoblotting with antibodies against Liprin-α1-4. The contrast was increased for the 
Liprin-α1 antibody labeling to allow visibility of the signal in the total brain protein lysate. (D), 
The Liprin-α antibody signals of the immunoblot shown in C were analyzed using the 
software AIDA and the signal intensity was plotted against the amount of peptide loaded in 
ng. (E), Liprin-α3 is the most abundant isoform in the brain. The relative expression of the 
four Liprin-α isoforms was calculated by comparing the intensity values of each isoform 
detected in whole brain lysate. Intensity values of two lanes were averaged for the 
calculations. Quantification was performed using immunoblots blocked with either 2% gelatin 
or 10% milk.  
 
 
D 
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To examine the relative abundance of the four isoforms in brain we determined the 
affinity of the antibodies. The results from this quantification suggest that in the 
adult mouse brain Liprin-α3 is the family member with the highest and Liprin-α1 the 
one with the lowest abundance (Liprin-α3 > Liprin-α2 > Liprin-α4 > Liprin-α1) (Fig. 
5.7C-E). 
5.2.3. Spatiotemporal expression pattern of Liprin-α 1-4  
Immunoblot analysis revealed that Liprin-1α is the only isoform detected in all tissues 
tested, being most strongly expressed in brain, lung and testes (Fig. 5.8A). Liprin-α3 
and -α4 expression is restricted to the brain, whereas Liprin-α2 is detected at very 
low levels also in testes in addition to a prominent expression in brain. In 
accordance with the mRNA data, all Liprin-α proteins are present in all brain regions 
tested (Fig. 5.8B). 
 
Fig. 5.8: Liprin-α1-4 exhibit distinct spatiotemporal expression profiles.  
(A-C), Immunoblot analysis of the expression of Liprin-α1-4 in various tissues (A), brain 
regions (B) and during brain development (C). GAPDH or ß-actin antibodies were used as 
loading controls. (D), For the different brain regions the relative intensity values of Liprin-α 
signal compared to ß-actin were calculated and plotted in a graph, AU: arbitrary units. For 
Liprin-α1 all values were multiplied by 10. Immunoblots were analyzed using the software 
AIDA. OB, olfactory bulb; CX, cortex; ST, striatum; HC, hippocampus; TH, thalamus; MB, 
midbrain; CB, cerebellum; BS, brain stem. 
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Here, Liprin-α1 is most strongly expressed in the olfactory bulb and the cerebellum. 
Liprin-α2 and -α3 levels are highest in the forebrain and decline towards midbrain 
and brain stem (Fig. 5.8B). In direct comparison, Liprin-α2, is present at higher levels 
within the olfactory bulb, where Liprin-α3 is only weakly expressed. Liprin-α4 protein 
levels are highest in the cerebellum. 
To gain insight into the function of Liprin-α in brain development, we determined their 
ontogenetic protein expression profile in mouse brain (Fig. 5.8C). All Liprins-α are 
already expressed at early embryonic stages (E12.5). We found that levels of Liprin-
α2, -α3 and -α4 increase during development and peak around day E18.5 in the 
case of Liprin-α2 and -α4 and around P10 for Liprin-α3 (Fig. 5.8C). Strikingly, Liprin-
α1 exhibits an inverse time course of expression, being most prominently expressed 
at early embryonic stages of development and at lower levels after birth. These 
results demonstrate that Liprin-α proteins are coexpressed throughout the brain as 
well as during development and therefore have the potential to function in the same 
protein complexes. Intriguingly Liprin-α1 exhibits a distinct spatial and temporal 
expression profile indicative for a potentially diverging functional role. 
5.2.4. Distribution of Liprin-α1-4 in the cerebellum and hippocampus 
To resolve the distribution of Liprin-α1-4 at the cellular level we performed 
immunohistochemistry with the newly generated isoform specific antibodies (Fig. 
5.9). Confocal immunofluorescence microscopy revealed that in the molecular 
layer of the cerebellum the strongest immunoreactivity is observed for Liprin-α4 
(Fig. 5.9A). The signal shows a high degree of overlap with the labeling for 
synaptophysin indicating a synaptic localization. A similar distribution pattern albeit 
at lower intensity was found for Liprin-α1. Labeling with antibodies against Liprin-
α2 resulted in a strong staining of the granule and purkinje cell layers, where the 
Liprin-α3 antibody resulted a comparable distribution but a weaker signal. In the 
cerebellar molecular layer immunoreactivity for both Liprin-α2 and -α3 was 
observed in the soma of dispersed cells, most likely of interneurons of the stellate 
or basket cell type.  
In the CA3 region of the hippocampus all four Liprin-α isoforms show co-staining 
with synaptophysin in stratum lucidum (SL), though to a varying degree (Fig. 5.9B). 
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Fig. 5.9: Immunohistochemical localization of Liprin-α1-4 in the cerebellum and 
hippocampus.  
Confocal scanning micrographs of sagittal cryo-sections of adult rat cerebellum and 
hippocampus were double labeled with antibodies against Liprin-α1-4 and synaptophysin. 
(A), In the cerebellum, Liprin-α4 is the isoform showing the strongest immunoreactivity in the 
molecular layer and exhibiting a synaptic expression pattern, similar to the weaker Liprin-α1 
while Liprin-α2 and -α3 show a strong staining in the granule and purkinje cell layer. GCL: 
granule cell layer, PC: purkinje cell layer, ML: molecular layer. (B), In the hippocampal CA3 
region of the hippocampus all four Liprin-α isoforms show co-labeling with synaptophysin in 
stratum lucidum, though to a varying degree. SO, stratum oriens; SP, stratum pyramidale; 
SL, stratum lucidum; SR, stratum radiatum. (C), In the dentate gyrus (DG) Liprin-α4 shows 
strong staining in the stratum moleculare while Liprin-α1, -α2 and -α3 can only be weakly 
detected. Interestingly Liprin-α2, -α3 and -α4 label putative interneurons in the hilus. SG, 
stratum granulosum; PL, polymorphic layer; SM, stratum moleculare. Scale bar: 200µm; 
higher magnification in A scale bar 50µm. 
 
While Liprin-α1 was most prominently expressed in the SL mossy fibres, Liprin-α2 
expression was more strongly detected in the cell bodies in the stratum pyramidale 
(SP), and Liprin-α3 and -α4 showed only very weak signals. In the dentate gyrus 
(DG) on the contrary (Fig. 5.9C), Liprin-α4 shows strong staining in the stratum 
moleculare (SM), where Liprin-α1, -α2 and -α3 proteins can only be weakly 
detected. Liprin-α2 and -α3 are most strongly expressed in the DG stratum 
granulosum and together with Liprin-α4 they are present in putative interneurons in 
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the hilus (PL).  
5.2.5. Differential localization of Liprin-α1-4 in the retina 
Double staining of retinal sections with Liprin-α1-4 and CtBP2 antibodies revealed 
that Liprin-α isoforms are distributed differentially in the retina (Fig. 5.10). The 
patterns are overlapping but show a distinct distribution of Liprins-α in synaptic and 
extrasynaptic regions. CtBP2 antibodies label the presynaptic cytomatrix protein 
RIBEYE at the active zones of ribbon synapses in the two synaptic layers of the 
retina - the inner and outer plexiform layers (IPL, OPL) and the transcriptional co-
repressor CtBP2 in nuclei of the inner nuclear layer (INL) and are therefore a useful 
marker for synaptic orientation in the retina. The Liprin-α1 antibody labeled both 
retinal synaptic layers arguing for a synaptic localization of Liprin-α1. In the outer 
plexiform layer the staining is most likely postsynaptic since Liprin-α1 staining is 
oriented towards the inner retina with respect to the presynaptic RIBEYE/CtBP2 
immunoreactivity in the OPL. In addition, a cell type spanning the whole inner retina 
from the ganglion cell layer to the outer plexiform layer is labeled by the Liprin-α1 
antibody, a pattern in accordance with Müller glia cell labeling. Likewise Liprin-α2 
exhibits a mainly synaptic localization with the most prominent labeling in two 
sublayers of the highly stratified IPL. Furthermore, somata in the INL were labeled, a 
region containing the cell bodies of amacrine and bipolar cells. Liprin-α3 showed an 
even more widespread distribution. Interestingly, no enrichment of immunolabeling 
was seen in the ribbon synapses of the OPL. However, synaptic staining was 
obvious in the IPL in addition to a prominent somatic staining in the inner and outer 
nuclear layers. In contrast to the OPL that contains only ribbon synapses, the IPL 
contains ribbon and conventional synapses.  
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Fig. 5.10: Differential but overlapping expression of Liprin-α1-4 in the retina. 
Confocal microscopy images of vertical mouse retina sections labeled with antibodies 
against Liprin-α1-4 and CtBP2. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, 
inner nuclear layer; IPL, inner plexiform layer. Scale bar: 50µm. Performed by S. tom Dieck. 
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Thus, the different immunolabeling of OPL and IPL could arise from the absence of 
Liprin-α3 from ribbon synapses. The Liprin-α4 antibody homogeneously labeled 
photoreceptor somata in the ONL. Faint labeling of Liprin-α4 was also seen in the 
synaptic layers. In contrast to Liprin-α1 the diffuse label in the OPL seems to 
surround and partially colocalizes with the RIBEYE/CtBP2 staining suggesting a 
presynaptic localization of Liprin-α4 at photoreceptor ribbon synapses. 
Immunohistochemistry of retinae from Bassoon knockout mice that allow to 
differentiate between ribbon- or arciform density associated proteins (tom Dieck et 
al., 2005) did not reveal a differential distribution for Liprin-α1-4 (data not shown). 
5.2.6. Subcellular localization of Liprin-α1-4 in neurons 
Liprin-α2 has been described to be present at pre- and postsynaptic sites by 
immuno-electron microscopy using an antibody against the highly homologous N-
terminal domain (Wyszynski et al., 2002). To investigate the distribution of individual 
Liprin-α proteins in neurons we performed double immunostainings of DIV14-21 
cortical and hippocampal neurons for the Liprin-α isoforms and several pre- and 
postsynaptic marker proteins (Fig. 5.11). All four Liprin-α family members can be 
detected in primary cortical and hippocampal neurons (Fig. 5.11A). Liprins-α are 
present in dendrites and axons and could also be detected in the soma to a varying 
degree. Liprin-α2 and -α3, the predominantly expressed isoforms in the brain, 
exhibited a mostly punctate staining pattern. Significant colocalization was observed 
in double immunolabelings with the presynaptic markers Bassoon (Fig. 5.11A) as 
well as with the postsynaptic marker PSD-95 (Fig.5.11.B). Liprin-α1 and -α4 could 
only be detected at low levels in a punctate pattern with some of the signal being 
diffuse. Double immunolabeling with primary neurons with antibodies against Liprin-
α1-4 and GAD67, a marker for inhibitory neurons, revealed that all four isoforms are 
present in GABAergic cells (Fig. 5.11C). 
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Fig. 5.11: Subcellular localization of Liprin-α1-4 in primary neurons.  
Immunocytochemistry of primary neurons DIV14-21. Presynaptic active zones were labeled 
by Bassoon (A), the PSD was labled by PSD-95 (B) and inhibitory neurons by GAD67 (C). 
Scale bar: (A), 50µm, (B) 5µm. 
5.2.7. Liprin-α1-3 accumulate at the leading edge of growth cones 
Liprins-α have been suggested to play a critical role in synaptogenesis and active 
zone formation. Therefore, we examined which Liprin-α family members are 
present in outgrowing axons and where they are located within the growth cone. 
Immunolabeling of hippocampal neurons at DIV4 revealed that all four Liprin-α 
isoforms are present in growth cones (Fig. 5.12). Liprin-α2 and -α3 show a strong 
accumulation at the edge of the peripheral region of the growth cone. This 
distribution pattern is also observed for Liprin-α1, albeit less pronounced. In 
contrast, Liprin-α4 is found only weakly throughout the growth cone in a punctate 
manner. We performed double immunolabelings with two active zone proteins, 
RIM1α and Bassoon (Fig. 5.12A and B, respectively). The staining patterns of RIM1α 
and Liprin-α1, -α2, and -α3 show a substantial degree of overlap at the leading edge 
of the growth cone (Fig. 5.12A). Bassoon exhibits a distinct punctate pattern of 
C 
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distribution throughout the growth cone and is not enriched at the leading edge (Fig. 
5.12A). Only a minor degree of colocalization was observed with the four Liprin-α 
isoforms.  
 
 
 
A 
Liprin RIM1α     merge 
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Fig.5.12: Distribution of Liprin-α1-4 in neuronal growth cones.  
Liprin-α1, -α2 and -α3 accumulate along the leading edge of the growth cone while Liprin-a4 
shows an evenly distributed punctate pattern. Primary neuronal cultures were analyzed at 
DIV4 by confocal microscopy after double immunolabeling for Liprin-α1-4 and RIM (A) or 
Bassoon (B). Scale bar: 10µm. 
B 
Liprin Bassoon    merge 
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5.2.8. Liprin-α1 is the predominant Liprin-α isoform in glial cells 
A comparative transcriptome study of neurons, astrocytes and oligodendrocytes 
suggested that Liprin-α1 is the most abundant Liprin-α isoform in glial cells while 
Liprin-α2, -α3 and -α4 were only detected at very low levels (Cahoy et al., 2008). The 
results of our immunolabeling of cultured astrocytes confirmed this observation as we 
found Liprin-α1 to be present in this cell type at high levels whereas the signals for 
the other three isoforms were close to background (Fig. 5.13A). Interestingly, Liprin-
α1 in astrocytes, identified by double labeling with an antibody against GFAP, was 
mainly localized at distinct areas near the edge of processes. 
 
Fig. 5.13: Liprin-α1 is the predominant Liprin-α  in glial cells and is mainly 
localized in clusters at the rim. 
Immunocytochemistry of primary glia DIV14-21. Astrocytes were colabeled with an antibody 
against GFAP. Scale bar: 50µm. 
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5.3 Analysis of Liprin-α2 localization and dynamics in primary 
neurons using overexpression 
Liprins-α have been described as integral components of the protein network at the 
presynaptic active zone where they interact with many different active zone proteins, 
e.g. RIM1α a protein that links SVs to Ca2+-channels and plays an important role in 
SV priming (Coppola et al., 2001; Kiyonaka et al., 2007; Mittelstaedt et al., 2010 
). However, as shown in chapter 5.2 Liprins-α are not like RIM1α purely presynaptic 
proteins but also present throughout dendrites and at the popstsynaptic density. 
Liprins-α share a highly conserved domain structure but so far it is unclear which 
domain and binding partners are critical for the association of Liprins-α to the CAZ 
(cytomatrix at the active zone) and how Liprins-α are targeted to the synapse.  
5.3.1. GFP-Liprin-α2 is located at focal clusters in the presynaptic bouton 
To study the dynamic properties of Liprin-α2 we generated a plasmid expressing a N-
terminal fusion protein of the fluorescent reporter GFP and Liprin-α2. As tags can 
affect localization we first verified correct targeting in primary neurons by comparing 
the distribution of the overexpressed fusion protein to the endogenous Liprin-α2.  
The N-terminal GFP-Liprin-α2 fusion protein transfected into primary hippocampal 
neurons can be detected in axons and dendrites while its interaction partner at the 
active zone, GFP-RIM1α, is only present in the axon (Fig.5.14A). Both proteins show 
an enrichment at boutons along the axon. This result is in accordance with 
observations from immunostainings with the respective antibodies. When GFP-Liprin-
α2 and cherry-RIM1α are cotransfected a very strong colocalization at synaptic 
boutons is detected (Fig. 5.14B). This suggests that the cotransfection of the 
interaction partners increases their synaptic localization as it has been shown for 
Liprins-α and ELKS (Ko et al., 2003a). To study the distribution of GFP-Liprin-α2 at 
the bouton we labled the presynaptic bouton, that is filled with synaptic vesicles, by 
cotransfecting the synaptic vesicle transmembrane protein SV2A. High magnification 
micrographs revealed that GFP-Liprin-α2 is not ubiquitiously distributed throughout 
the presynaptic bouton but appears to be clustered in subcompartments along the 
membrane.  
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Fig. 5.14: Overexpression of GFP-Liprin-α2 in primary hippocampal neurons. 
Cells were tranfected DIV3-6 and fixed for imaging at DIV14.  
(A) GFP-Liprin-α2 is present throughout the neuron while RIM1α expression is restricted to 
the axon. (B) Coexpressed GFP-Liprin-α2 and cherry-RIM1α strongly colocalize at synaptic 
boutons. (C) Coexpression of GFP-Liprin-α2 and cherry-SV2, a synaptic vesicle protein, 
shows that GFP-Liprin-α2 is restricted to focal clusters at the bouton. 
5.3.2. Localization of Liprin-α deletion mutants 
The domain structure of Liprins-α is highly evolutionary conserved and binding 
partners have been identified for most regions. However, little is known about how 
these domains and their interaction partners relate to the targeting of Liprins-α and to 
their described functional role, e.g. in dendritic branching. To gain insight into the 
functional role of the coiled-coil domain in the N-terminal half and the three SAM-
domains followed by the PDZ binding motif in the C-terminal half we generated 
deletion contstructs coding for GFP fusion proteins. GFP-deletion variants were first 
expressed in NG108 cells to test for their expression and stability. In NG108 cells the 
full-length GFP-Liprin-α2 as well as the fusion proteins containing the coiled-coil 
domain, which mediates dimerization, showed a punctate accumulation throughout 
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the cell. The GFP-SAM-domains and GFP transfected as a control were ubiquitously 
distributed. Next, primary neurons were analysed at DIV7, when the axons are 
already well developed but dendrites are just growing out, and at DIV14, when 
cultured neurons are mature, for analysis of the cell morphology. For Liprin-α1 it was 
shown that overexpression of the N-terminal half at DIV13 leads to decreased 
arborisation of the dendritic tree at DIV17 (Hoogenraad et al., 2007). Here, no 
obvious changes in arborisation in neurons transfected with deletion constructs of 
Liprin-α2 were observed at both time points. No unique targeting domain could be 
identified all deletion mutants were present in dendrites and axons and no diverging 
distribution was detected. 
 
Fig.5.15: Effect of overexpression of deletion constructs on cell morphology. 
Full-length GFP-Liprin-α2 as well as the N-terminal and C-terminal part of Liprin-α2 
tagged with GFP were transfected in NG108 cells as well as in DIV3-4 hippocampal 
neurons. As control GFP was transfected. Cells were fixed for imaging at DIV 7 and 
DIV14.  
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5.3.3. Dynamics of RIM1α and Liprin-α2 at the presynaptic bouton 
In recent years the dynamics of several presynaptic proteins were elucidated. 
Depending on the localization of proteins either on a synaptic vesicle or integrated 
into the CAZ and on their functional role, the dwell time at the presynaptic bouton can 
range from minutes to hours. For synaptic vesicle proteins like synapsin the 
exchange time constant at the presynaptic bouton is in the minute range while the 
large scaffolding protein Bassoon has an exchange time constant that exceeds 8 
hours (Tsuriel et al., 2006; Tsuriel et al., 2009). To gain insight into the stability and 
exchange rates of Liprin-α2 and its interaction partner RIM1α we used two 
approaches, fluorescence recovery after photobleaching (FRAP) and fluorescence 
recovery after photoactivation (FRAPA), where a photoactivatable GFP (paGFP) is 
employed, recorded by time-lapse confocal microscopy (Fig. 5.16). 
Individual putative presynaptic sites of transfected rat hippocampal neurons are 
selected. In FRAPA experiments CFP was cotransfected to enable selection of 
putative presynaptic sites since paGFP is hardly visible before activation. After 
collecting baseline images multiple sites were selectively bleached or activated and 
the loss and reincorporation was monitored at rates of every 10 minutes for FRAP 
experiments and every 1h for FRAPA experiments. To verifiy that the bleaching or 
photoactivation procedure does not affect the functionality of the synapse high KCl 
stimulation was used to label all boutons in the fields of view with the fluorescent 
functional endocytosis marker N-(3-triethylammoniumpropyl)-4-(p-dibutylaminos-
tyryl) pyridinium, dibromide (FM4–64, 15 lM) (Fig. 5.16C). 
The two different approaches have different advantages and disadvantages. The 
EGFP used in FRAP experiments allows a high sampling rate but errors arising from 
photo-bleaching lead to an underestimation of recovery rates and are more 
significant near the end of the recovery phase. This is critical for correct estimations 
of slow exchange rates. In FRAPA, photobleaching is about twice as pronounced and 
leads to an overestimation of exchange rates and errors arising from photo-bleaching 
are extremely significant at the initial phase of recovery.  
In initial experiments for RIM1α an exchange rate in the range of minutes was 
observed while Liprin-α2 showed much slower dynamics. Due to these observations, 
FRAPA experiments were performed to access the exchange rate of Liprin-α2 (Fig. 
5.16 B) and FRAP experiments to analyse RIM1α dynamics (Fig. 5.16 D).  
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Fig.5.16: Dynamics of RIM1α  and Liprin-α2 at the presynaptic bouton. 
(A), Fluorescent recovery after photoactivation (FRAPA) of paGFP-Liprin-α2. 
Neurons were cotransfected with paGFP-Liprin-α2 and CFP to allow selection of 
putative pre-synaptic boutons for photo-activation. Axon expressing CFP (a) as well 
as paGFP-Liprin-α2, here shown befor activation (b) and at timepoint 0 (c), directly 
after photo-activation. 13 h after photoactivation there is still paGFP-Liprin-α2 
detectible at some boutons (d). (B) Dynamics of paGFP-Liprin-α2 at the presynaptic 
bouton are relatively slow. Primary rat cortical cultures were transfected with paGFP-
Liprin-α2 at DIV10 and imaged at DIV22. The residual fluorescence of photoactivated 
paGFP-Liprin at presynaptic boutons was imaged every hour. The average residual 
fluorescence of 10 sites was plotted against time. (C) Fluorescent recovery after 
photobleaching (FRAP) of GFP-RIM1α followed by a FM uptake assay. Rat primary 
cortical cultures were transfected with GFP-RIM1α at DIV10 and imaged at DIV22 
(a). As a control of functionality of the synapses imaged neurons were loaded with 
FM-64 at the end of the experiment (b). (c), overlay of a and b, (d) overlay of a, b and 
a DIC image. (D) Dynamics of GFP-RIM1α at the presynaptic bouton are relatively 
fast. The recovery of fluorescence of GFP-RIM1α after photobleaching was imaged 
every 10 minutes. The average residual fluorescence of four sites was plotted 
against time. Scale bar: 10µm (A) 7,5 µm (B). 
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For Liprin-α2, a scaffolding protein thought to be critical for active zone composition, 
a relatively slow exchange rate was observed. In the first three hours the residual 
fluorescence went down to about 40%. Even 7 h following photoactivation, when no 
further decrease in fluorescence was detected, residual fluorescence was observed 
at some boutons. It is likely that the recovery has two phases due to a slow and a 
fast exchange pool of proteins. RIM1α showed a much faster exchange rate, with an 
almost complete recovery of fluorescence 40 min after bleaching. 
5.4 Disruption of Liprin-α function 
Little is known about the diverging and overlapping functional roles of the four highly 
homologous Liprin-α isoforms in the mammalian brain. Many putative interaction 
partners have been identified and so far it is assumed that all interactions are 
common to all isoforms. Our analysis of the gene structure and alternative splicing 
showed that Liprins-α can be differentially regulated by alternative splicing in a 
development dependent manner. This could potentially change their affinity to 
specific interaction partners. The characterization of the expression patterns of the 
four Liprin-α isoforms revealed that Liprins-α show a distinct but overlapping 
distribution with Liprin-α2 and -α3 being the most abundant isoforms present at most 
synapses. To further investigate the functional roles of the Liprin-α2 and -α3 isoforms 
in neurons two approaches were chosen, a loss of function experiment and the 
interference with specific interactions. 
5.4.1. Identification of shRNAs 
To analyze the effect of the lack of single Liprin-α isoforms on neuronal morphology 
as well as synapse formation and maintenance we chose to use an shRNA 
approach. We first tested four shRNAs for each isoform by cotransfecting shRNAs 
and the target Liprin-α in HEK-293T cells. The quantitative analysis of the 
immunoblot of HEK-293T cells three days after transfection yielded one shRNA for 
Liprin-α1 and -α2 which showed a significant knock down of the respective protein 
(data not shown). Since we wanted to focus on Liprin-α2 and -α3 seven additional 
shRNAs targeting these two most abundant expressed isoforms in the b rain were 
analyzed. To directly test the ability of the new shRNAs as well as the before 
identified candidate shRNA against Liprin-α2 to downregulate the endogenous 
protein primary neuronal cultures were transduced using rAAV viruses. Viral particals 
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were added to primary cortical cultures on DIV0-1 and cells were harvested for 
immunoblotting on DIV12-14. The immunblots were quantified using the AIDA 
software. For the quantification of the knock-down the levels of Liprin-α were 
normalized to α-tubulin and cells transduced with shRNAs were compared to cells 
transduced with the empty vector. Two shRNAs, one for each isoform, were found to 
be efficient in the down regulation of the Liprin-α protein levels. The knock-down 
efficiency was 80% for Liprin-α2 (shRNA 1469) and 80-85% for Liprin-α3 (shRNA 
1644), respectively (Fig. 5.17A, B). The other shRNAs tested did not show a 
sufficient down regulation of the target protein.  
As a first test to examine if the knock-down of Liprin-α3, the most abundant Liprin-α 
isoform leads to a drastic change in neuron morphology, as for example observed for 
its interaction partner GRIP1 (Hoogenraad et al., 2005), viral particles were added at 
DIV1 to primary neurons which were analyzed at DIV5 and DIV14. A first analysis of 
the effect of the down regulation of Liprin-α3 showed no obvious impact on the 
morphology of the neurons (Fig. 5.17C). At DIV5, when axons are already well 
developed but dendrites are just growing out, no change in axon development was 
observed. In adult cortical neurons at DIV14 no change in dendrite or spine 
morphology was detected and axon morphology seemed unchanged.  
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Fig. 5.17: Identification of shRNAs to specifically knock down Liprin-α2 and α3 
(A), The knock-down efficiency of shRNAs was analyzed by immunoblotting of 
lysates of DIV13-14 old cortical primary neurons treated on DIV0-1 with rAAV virus 
containing a shRNA plasmid or empty vector as control. (B), The Liprin-α antibody 
signals of the immunoblots shown in (A) were quantified using the AIDA software 
with α-tubulin as an internal control. (C), Cortical primary neurons treated with rAAV 
Virus containing a shRNA plasmid or the empty vector as control on DIV1 were fixed 
and imaged with a confocal laser scanning microsope on DIV5 and DIV14. Scale bar: 
50µm.  
5.4.2. Identification of point mutations to disrupt specific interactions 
To study the role of individual binding partners for Liprin-α function specific 
interactions need to be disrupted. Therefore, point mutations should be inserted in 
the interaction domains of Liprin-α or its binding partners to lower the binding affinity. 
As no structural data for Liprins-α are available to date, the Liprin-α tertiary structure 
was modeled based on existing structures (in collaboration with Carsten Reissner, 
Institute for Anatomy, University Münster). This model was used to identify point 
mutations that were predicted to disrupt the interaction between Liprin-α2 and RIM1α 
B 
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as well as Liprin-α homodimerization.These analyses provided one point mutation in 
the coiled-coil domain of Liprin-α (L294D) that was predicted to disrupt Rim1α 
binding as well as homodimerization of Liprins-α and a mutation in the RIM1α C2B 
domain (T1454Q) that was predicted to disrupt the RIM1α-Liprin-α2 interaction. The 
mutations were introduced in the Liprin-α2 and RIM1α sequence by site directed 
mutagenesis. Subsequently the ability of these point mutations to disrupting the 
interaction was tested in pull down assays.  
In the pull down assay to test the effect of the mutation in the RIM1A C2B domain on 
the binding to Liprin-α2 the mapped interaction domains for the RIM1α-Liprin-α 
binding were used. Since the Liprin-α2 coiled-coil domain was relatively instable 
without the GST it was purified from bacteria as a GST-fusion protein and the RIM1α 
C2B domain was overexpressed in HEK-293T cells as a HA-tagged protein. In this 
assay the mutation in the RIM1α C2B domain successfully disrupted the binding to 
the Liprin-α coiled-coil domain (Fig. 5.18 A). 
 
 
Fig. 5.18: Identification of point mutations to disrupt the Liprin-α2 interaction  
(A), (B), Schematic drawings depict the constructs used in each pull down assay. 
The interaction domains of Liprin-α and RIM1α are depicted with the respective tag. 
The point mutation is indicated with a red asterisk and the exchanged amino acid is 
noted above. For the pull down assay GST-fusion proteins were purified and 
incubated with the binding partner overexpressed in HEK-293 cells. Binding was 
analyzed by immunoblotting using an anti-HA antibody. RBD: RIM binding domain, *: 
mutation 
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To test the effect of the mutation in the Liprin-α2 leucin-zipper motif of the coiled-coil 
domain on the homodimerization a pull down with the coiled-coil domain of Liprin-α 
was performed. Here the same domain was once purified from bacteria as a GST-
fusion protein and also overexpressed in HEK-293T cells with a HA-tag. In this assay 
the mutation in the coiled-coil domain did not have an influence on the Liprin-α 
homodimerization (Fig. 5.18B).  
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6 Discussion 
6.1 Liprins-α share a similar genomic organization but are 
differentially regulated by alternative splicing 
In recent years studies in C. elegans and Drosophila have identified the Liprin-α 
family of scaffolding proteins as a key player in synapse development and 
maintenance as well as in intracellular transport (Spangler and Hoogenraad, 2007; 
Stryker and Johnson, 2007b). So far, relatively little is known about the mammalian 
Liprin-α orthologs. To gain insight into the overlapping and diverging properties of the 
Liprin-α protein family in mammals we carried out a comparative characterization of 
the human and mouse Liprin-α gene structure and their regulation by alternative 
splicing.  
6.1.1. Phylogenetic analysis 
The phylogenetic analysis of the Liprin-α family revealed that in accordance with 
their presumably fundamental functional role Liprin-α homologs are present 
throughout all invertebrate and vertebrate genomes. Whereas C. elegans and 
Drosophila each express one single Liprin-α gene, Liprins-α were diversified early 
during evolution into a family consisting of four genes as present in danio rerio, 
mouse or human. Liprin-α proteins exhibit a remarkable degree of overall amino acid 
identity and similarity within the human and mouse families and are highly conserved 
from C. elegans to human in several regions. However, these regions of striking 
similarity between species as well as between isoforms only partially coincide with the 
experimentally mapped sites of protein interaction. The SAM-domains and adjacent 
linker sequences constitute the regions with the highest degree of homology. In 
contrast, the RIM and ELKS binding domains are composed of highly homologous 
and quite diverging sequences. The region of the RIM interaction site is preceded by 
a sequence that is highly conserved from C. elegans to humans. No function or 
binding partner for this region has been described to date. In contrast, a novel site of 
protein interaction has only been added later during evolution. The C-terminal PDZ 
consensus binding site is not present in C. elegans and Drosophila but found in Danio 
rerio and higher mammals (Suppl. Fig. 1). This is surprising as the only known 
binding partner for this motif, GRIP, is also expressed in C. elegans and Drosophila. 
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6.1.2. Exon-intron structure of human and mouse Liprins-α 
The diversification of Liprin-α genes into a complex gene family has led to multiple 
shared properties in their exon-intron structure but has also resulted in various 
differences in their genomic organization. On the one hand, the size and composition 
of their exons is very similar and the splice acceptor/donor site phases are conserved 
among all four genes. On the other hand, the size of the genes varies from very 
large, with approximately 500 kb for Liprin-α2, to small, with approximately 30 kb for 
Liprin-α3. In Liprin-α1 and Liprin-α2, the second exon containing the translation start 
site is separated from the remaining clustered exons by an intron half the size of the 
whole gene. In the case of Liprin-α2 an additional short exon that is found in all 
Liprin-α2 transcripts is present in this large intron. This exon represents the only 
constitutive exon that is solely found in one Liprin-α isoform. Its presence in the 
Liprin-α2 proteins interrupts the N-terminal region of high homology between the 
isoforms with unknown functional consequences. In addition, whereas in Liprin-α1, -
α2, and -α3 the first exon contains only untranslated sequence, in Liprin-α4 all exons 
are comprised of protein-coding sequence. Therefore, while Liprin-α2 and Liprin-α4 
proteins are the closest family members on the amino acid level, their gene size and 
structures are quite different. 
The high degree of sequence conservation at the protein level between the human 
and mouse Liprin-α orthologs is also reflected in the similarity of their genomic 
organization. The lengths of the introns are highly comparable for the human and 
mouse Liprin-α orthologs and identical for their exons. However, major differences 
were found in the splice patterns of Liprin-α1, -α2, and -α4 transcripts for the human 
and mouse orthologs. We have identified six sites of alternative splicing in Liprin-α 
genes in human and five in mice. Whereas in many synaptic protein families sites of 
alternative splicing are conserved between family members, e.g. RIMs (Wang and 
Sudhof, 2003), RIM-BPs (Mittelstaedt and Schoch, 2007), and Neurexins (Tabuchi 
and Sudhof, 2002), only one of these splice sites was used in all human Liprin-α 
isoforms and none of them in all mouse Liprin-α isoforms. In the case of the observed 
difference between the human and mouse Liprin-α1 and Liprin-α4 variants the 
divergence in alternative spliced exons was due to the fact that the alternatively 
spliced sequence of the human Liprin-α is not present in the mouse genome. Further 
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studies will be required to address the biological relevance of human and mouse 
splice variants to synapse development and membrane organization. 
6.1.3. Alternative splicing is developmentally regulated 
It is striking that despite the similarities in their genomic organization and their strong 
homology at the protein level Liprins-α are differentially regulated at the post-
transcriptional level. Liprin-α1, the turnover of which is regulated by synaptic activity 
through APC and CaMKII (Hoogenraad et al., 2007), is the isoform most prone to 
functional variability that could arise from alternative splicing. One Liprin-α1 splice 
product contains an insertion in the ELKS binding domain; in a second splice product 
a short sequence in the linker between the coiled-coil region and the SAM-domains is 
either present or absent; and a third splice variant alters the distance between the 
first and second SAM-domain. However, the most remarkable alteration is caused by 
alternative splicing of the C-terminal exons, which results in transcripts encoding 
proteins with three (human) or two (mouse) C-termini. Diverging C-termini have 
already been described for the human Liprin-α1 (Serra-Pages et al., 1995). We now 
report that in the mouse Liprin-α1 gene alternative splicing generates transcripts with 
alternate C-termini and that this new splice pattern can be found in human 
transcripts, too. Therefore, three human C-terminal splice variants are expressed. 
Liprin-α4 had been described as the only Liprin-α isoform that did not contain the C-
terminal PDZ interaction motif (Katoh, 2003). In this analysis we have identified a 
Liprin-α4 transcript variant in human and mouse that encodes the conserved seven 
amino acid stretch present in the other Liprin-α isoforms. This C-terminal PDZ 
interaction motif mediates the binding of Liprins-α to the adaptor protein GRIP. 
Thereby, alternative splicing at the C-terminus directly affects the interaction of 
Liprin-α1 and -α4 with GRIP. No GRIP-binding deficient variants exist of Liprin-α2 
and -α3, which are the most abundant Liprin-α isoforms at later stages of 
development and in mature neurons. Also, in the case of Liprin-α1 the isoform most 
prominently expressed throughout development contains the PDZ-interaction motif. 
Only for the Liprin-α isoform with the lowest abundance, Liprin-α4, is the GRIP-
binding deficient variant the major transcript expressed. GRIP binds to the PDZ-
binding motif at the C-terminus of GluR2. By neuronal overexpression of C-terminal 
GluR2 point and deletion mutants, in which GRIP binding was abolished, it was 
shown that this region is essential for the surface accumulation of the GluR2 
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receptors in neurons (Osten et al., 2000). These results suggested that GRIP is not 
required for normal targeting of GluR2 to the synaptic surface but contributes to the 
stabilization of AMPA receptors at the synaptic surface. Overexpression of the 
human-specific Liprin-α1 variant, which does not contain the PDZ-interaction motif 
and therefore can not bind to GRIP, lead to a reduced number of AMPA receptor 
clusters along dendrites and a diffuse localization of AMPA receptors in the soma 
and dendrites (Wyszynski et al., 2002). Therefore, Liprin-α seems to act as a 
targeting molecule to recruit GRIP and associated proteins to postsynaptic sites or 
that Liprin-α  plays a role in trafficking or transport of the GRIP complex. Due to the 
multiple interactions of Liprin-α with several components of the postsynaptic 
specialization, like LAR-RPTPs, GIT1, CASK, and CaMKII, the Liprin-α-GRIP 
complex may be required for the retention of AMPA receptors, containing the GluR2 
subunit, at the surface membrane or could be involved in the regulation of AMPA 
receptor internalization. AMPA receptors are critically involved in synaptic function 
and plasticity and therefore mechanisms that regulate targeting and surface 
expression of the receptors play an important role in these processes (Isaac et al., 
2007). In the adult brain Liprin-α isoforms, that can not interact with GRIP are only 
expressed at low levels. Increasing the level of the non-GRIP-binding Liprin-α 
variants could provide a mechanism by which neurons control the number of AMPA 
receptors targeted to the postsynaptic compartment and expressed at the 
postsynaptic surface. Future studies will be required to determine the signals that 
control these alternative splice events as well as their precise role. 
 Even though 206 SAM domains can be identified in human proteins and 178 in 
mouse, mainly single SAM-domains are found in the context of large multidomain 
proteins (Qiao and Bowie, 2005). Liprins-α contain three closely spaced tandem 
SAM-domains. In Liprin-α1, -α3, -α4, and in human but not mouse Liprin-α2 
alternative splicing controls the distance between the first and second SAM-domain. 
In the proteins lacking the alternatively spliced exons the SAM-domains are only 
separated by 11 amino acids. Structural and biochemical studies are necessary to 
delineate the resulting functional implications. We furthermore show that usage of 
alternative exons in most cases is regulated throughout development. 
Synaptogenesis is associated with structural and functional alterations and several 
aspects of this process have been shown to be regulated by the complex alternative 
splicing of proteins, such as agrin, the protocadherins, neurexins, and neuroligins (Li 
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et al., 2007). Liprins-α on the other hand have been reported to play a role in 
photoreceptor axon targeting in Drosophila (Choe et al., 2006; Hofmeyer et al., 2006) 
and the development of excitatory synapses (Dunah et al., 2005). Accordingly, this 
analysis shows that alternative splicing constitutes a means by which Liprins-α can be 
modified in a developmental manner and by which the properties of the individual 
isoforms can be diversified independently. 
6.2 Liprins-α display overlapping and diverging spatiotemporal 
and subcellular expression patterns 
The single Liprin-α homolog in invertebrates is crucial for synapse formation and 
function. During evolution Liprin-α genes were diversified leading to four isoforms in 
mammals. Despite the high degree of homology increasing evidence suggests that 
the different Liprin-α isoforms can exhibit diverging functional and biochemical 
properties (Hoogenraad et al., 2007; Zurner and Schoch, 2009). Our analysis of the 
developmentally dependent alternative splicing of individual Liprin-α isoforms 
highlights one way in which single Liprins-α and their binding properties can be 
modified. The characterization of the expression pattern of the Liprin-α isoforms and 
thus the overlapping and distinct regional and/or subcellular localization of the 
Liprins-α could indicate further diverging functional roles.  
6.2.1. mRNA expression profile of Liprin-α 1-4 
Using real-time PCR to gain a first insight into the expression pattern of Liprins-α we 
observed greatly varying mRNA expression levels in all tissues and brain regions 
examined. Whereas Liprin-α2 and -α3 are predominantly found in the brain with a 
similar pattern of distribution, Liprin-α1 is the major isoform outside the nervous 
system. mRNA levels of Liprin-α4 are very low in all tissues tested, with the highest 
expression detected in muscle. However, all four Liprin-α isoforms are present in all 
brain regions even though their strength of expression varies greatly. Our results 
indicate that the promoters of the four Liprin-α genes are regulated independently. 
This is supported by evidence from two recent studies. A paper by Mattauch et al. 
showed that the human Liprin-α4 is strongly upregulated under hypoxia while the 
other Liprin-α isoforms are not significantly changed (Mattauch et al., 2010). The 
promoter of Liprin-α4 is directly activated by binding of the hypoxia-inducible factor 
1α (HIF-1α). A study on the effects of pathophysiological activity on the expression of 
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active zone proteins using the Pilocarpine model of temporal lobe epilepsy showed 
that the four Liprins-α are diffentially regulated under these conditions. Liprin-α2 is 
strongly upregulated in the hippocampus 6 hours after status epilepticus while Liprin-
α4 is downregulated after status epilepticus at all time points studied (Personal 
communication T. Mittelstaedt). The expression of Liprin-α1 and -α3 show no strong 
regulation under these conditions. 
6.2.2. Protein expression profile of Liprin-α 1-4    
To analyze the protein expression pattern of Liprin-α1-4 we generated isoform-
specific antibodies. Using these antibodies we found that all four Liprins-α are 
expressed throughout the brain albeit with diverging abundance. Liprin-α2 and -α3 
are the predominant isoforms in the brain with ubiquitously high expression levels, 
confirming previous results obtained by northern blotting as well as our quantitative 
real-time RT-PCR data (Serra-Pages et al., 1998; Zurner and Schoch, 2009). Liprin-
α1 and -α4 show much lower overall expression levels evenly distributed throughout 
the brain, with stronger signals in areas of high cell density, like the cerebellar and 
the olfactory bulb granule cells. Divergent expression of Liprins-α is apparent in 
several distinct brain regions. In the cerebellum Liprin-α4, and to a lower extend 
Liprin-α1, are detected at high levels in the molecular layer on the protein level, 
indicating synaptic localization, while Liprin-α2 and -α3 protein is distinctly expressed 
in Purkinje Cells. Overlapping but distinct distribution patterns are also observed in 
the retina where immunolabeling against Liprin-α1 suggests a synaptic localization 
that in the OPL is most likely postsynaptic. In contrast to Liprin-α2 that is mainly 
found located at synapses, Liprin-α3 shows a more widespread distribution and may 
not be present at ribbon synapses. Liprin-α4 exhibits a faint labeling of the synaptic 
layers but in the OPL surrounds and colocalizes with RIBEYE/CtBP2 indicating a 
presynaptic localization. Interestingly, unlike other active zone enriched proteins, 
Liprins-α are not exclusively associated with one of the three defined compartments 
of the ribbon synapse, the ribbon-associated complex, the plasma 
membrane/arciform density-associated complex and the border area between these 
two complexes (tom Dieck et al., 2005). These results demonstrate that even though 
in most neuronal populations of the brain all four Liprin-α proteins are present each 
Liprin-α protein is characterized by a distinct expression profile.  
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6.2.3. Subcellular localization of Liprins-α  
Whereas the C. elegans Liprin-α, SYD-2, has been described as a presynaptic 
protein (Zhen and Jin, 1999), Dliprin-α and the mammalian Liprins-α are present in 
axons and dendrites (Kaufmann et al., 2002; Wyszynski et al., 2002). However, it is 
still unknown if all Liprin-α proteins are found pre- and postsynaptically or if individual 
isoforms are targeted preferentially to one side of the synapse. Even though the 
resolution of confocal microscopy does not allow for an unequivocal identification of a 
pre- or postsynaptic localization, double immunolabelings of primary neurons show 
the highest degree of colocalization between pres- as well as postsynaptic markers 
and Liprin-α2 and -α3, whereas staining for Liprin-α1 and -α4 show less synaptic 
staining. Taken together, this data suggests that all four Liprin-α proteins are present 
in axons and dendrites but are differentially enriched at pre- and postsynaptic sites. 
Analyses using high-resolution techniques like immuno-electron microscopy and 
STED microscopy will be required to further resolve the distribution in detail. 
6.2.4. Liprins-α are present in inhibitory neurons 
Co-immunolabeling show, that all four Liprin-α proteins are expressed by excitatory 
and inhibitory cells. In primary neuronal cultures Liprin-α1-4 are present in cells that 
are immunopositive for GAD67, a marker for inhibitory presynapses. In the hilus of 
the hippocampus immunoreactivity of Liprin-α2, -α3 and -α4 coincides with the 
distribution of putative interneurons and in the cerebellum Liprin-α2 and -α3 are 
distinctly expressed by Purkinje Cells and detected in putative interneurons in the 
molecular layer. These results argue that there is not one Liprin-α molecule specific 
for the organization of protein complexes in inhibitory neurons as has been described 
for the neuroligin protein family where neuroligin 2 is the isoform selectively 
expressed by inhibitory cells (Varoqueaux et al., 2004).  
6.2.5. Liprin-α1 displays a diverging spatial and temporal expression profile 
Intriguingly, the spatial and temporal expression profile of Liprin-α1 stands out from 
the other three members of the Liprin-α protein family. Expression levels of Liprin-α1 
protein during development were highest at the earliest time point tested (embryonic 
day 12.5) and decreased dramatically after birth. Furthermore, Liprin-α1 is the only 
isoform expressed ubiquitously outside of the brain and the main Liprin-α molecule in 
cultured glial cells where it is located in a restricted focal manner at the rim of the 
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cell. Liprin-α1 was found to colocalize with the receptor tyrosine phosphatase LAR at 
focal adhesions in non-neuronal tumor cell lines (Serra-Pages et al., 1995). 
Overexpression of Liprin-α1 enhanced cell spreading and the formation of 
lamellipodia and focal-adhesions at the cell edge while knock-down of Liprin-α1 
inhibited cell spreading (Shen et al., 2007; Asperti et al., 2009). These findings 
together with the observed expression profile suggest that Liprin-α1 might play a role 
in organizing protein complexes that are involved in cell migration during brain 
development.  
Table 6.1: Overview of the expression pattern of Liprin-α1-4. 
Organs Brain Synapse  
mRNA protein mRNA protein ICC IHC 
Inter-
neurons 
(ICC) 
Glia 
(ICC) 
Liprin-α1 + + + + + +++ + + 
Liprin-α2 liver, 
testes 
testes + + +++ ++ + - 
Liprin-α3 - - + + +++ ++ + - 
Liprin-α4 muscle, 
testes 
- + + + +++ + - 
The detected expression of Liprin-α isoforms using Real-time PCR (mRNA), 
immunoblotting (protein), immunhistochemistry (IHC) and immuncytochemistry (ICC) 
in the brain as well as tissues outside the brain. The signals detected at the synapse 
are graded + to +++. 
6.2.6. Liprins-α expression pattern in growth cones 
The analysis of Liprin-α expression in the growth cones of DIV4 neurons points in the 
direction of a similar functional role as Liprin-α1, -α2 and -α3 accumulate along the 
leading edge of the growth cone. The adhesion between growth cones and the 
extracellular matrix or adjacent cells is mediated via specific adhesion molecules, i. e. 
integrins, Ig cell adhesion molecules (IgCAMs), and cadherins (Bard et al., 2008). 
Liprin-α1 has been shown to play a role in the distribution and stabilization of β-
integrins (Asperti et al., 2009) and is linked indirectly to cadherins via LAR (Dunah et 
al., 2005) and to PIX via GIT1 (Ko et al., 2003b). In addition, there is evidence from 
Drosophila that Dliprin-α in concert with LAR and N-cadherin is required for the 
regulation of photoreceptor targeting (Choe et al., 2006; Prakash et al., 2009). 
Furthermore, the levels of Liprin-α1, but not Liprin-α2, are tightly regulated at the 
synapse by synaptic activity and are directly correlated to dendritic arbor complexity 
(Hoogenraad et al., 2007). This raises the question if all Liprin-α isoforms can 
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function as regulators of cell spreading and motility or if this function is restricted to 
Liprin-α1. 
6.3 Dynamics of Liprin-α2 at the presynaptic bouton 
The level of active zone enriched proteins need to be sustained in the absence of 
obvious spatial or structural boundaries between the presynaptic bouton and the 
axon. At the same time alterations in the synapse composition are critical for synaptic 
plasticity. It has been hypothesized that while many proteins have a high flux some 
scaffolding proteins have a very slow turn over and thus form the basis for synaptic 
tenacity (Owald and Sigrist, 2009).  
6.3.1. Localization of GFP-Liprin-α2  
GFP-Liprin-α2 fusion proteins are ubiquitously present throughout the neuron in 
primary neurons but are enriched at putative presynaptic boutons along the axon. 
GFP-Liprin-α2 coexpressed with its interaction partner cherry-RIM1α show an 
increased accumulation at putative presynaptic boutons. Possibly the coexpression 
enhances the targeting of GFP-Liprin-α2 to the presynaptic bouton. A similar effect 
has been reported for the interaction between Liprin-α1 and ELKS (Ko et al., 2003a). 
Due to the low levels of presynaptic GFP-Liprin-α1 the observed effect of 
coexpression was very strong. GFP-Liprin-α2 is already enriched at the presynapse 
and thus a comparable effect would not be expected. About the interdependence of 
ELKS and Liprins-α in regard to their localization to the mammalian presynaptic AZ 
nothing is known. In C. elegans the absence of Liprin-α/SYD-2 leads to a disrupted 
localization of RIM/unc-10 while Liprin-α/SYD-2 localization is unchanged in 
RIM/unc-10 mutants (Dai et al., 2006).  
GFP-Liprin-α2 shows a punctate localization at the presynaptic bouton. This could 
indicate that Liprin-α2 is restricted to certain subdomains of the active zone as it was 
observed for the Liprin-α homolog in Drosophila (Fouquet et al., 2009). At the NMJ 
Dliprin-α was shown to form distinct clusters at the edge of the active zone as labeled 
by Bassoon using STED microscopy. Further investigation using high-resolution 
microscopy, e.g. STED would be required to analyze the distribution of endogenous 
mammalian Liprin-α2.  
So far no targeting sequence has been identified for Liprins-α. In contranst to the 
post synaptic density (PSD) where many proeins are targeted via PDZ interactions 
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no distinct motif is known for active zone proteins. So far the only protein studied is 
Bassoon, a protein highly enriched at the active zone. It was shown that a central 
coiled-coil domain is critical but not sufficient for the targeting of Bassoon to the 
active zone using deletion mutants (Dresbach et al., 2003). To investigate the role of 
the structural domains for the targeting of Liprin-α as well as for the morphology of 
the neuron we transfected GFP-tagged deletion mutants containing the N-terminal 
half, only the coiled-coil domain or the C-terminal half.  
A decrease in arborisation of the dendritic tree at DIV17 was described for 
overexpression of the N-terminal half of Liprin-α1 at DIV13 (Hoogenraad et al., 
2007). Here we transfected Liprin-α2 deletion constructs at DIV 3-5 and imaged 
neurons at DIV7 as well as DIV14. We could not detect any obvious effects of the 
deletion mutants on the dendritic branching of the neurons or on the targeting. A 
more detailed investigation would be necessary to identify the role of the domains for 
targeting of Liprin-α including e.g. time lapse imaging to study the trafficking of 
Liprins-α into the axon and dendrites. 
6.3.2. Dynamics of Liprin-α2 and RIM1α at the presynapse 
FRAPA experiments suggest that the scaffolding protein Liprin-α2 has a slow turn 
over at the presynapse while its interaction partner RIM1α shows faster dynamics in 
the performed FRAP experiments. In the FRAP experiment GFP-RIM1α signal had 
completely recovered 40 min after bleaching of the presynaptic bouton. A residual 
paGFP-Liprin-α2 signal could still be detected at some boutons after 8h in the 
FRAPA experiments while about 40% of the signal was lost from the presynaptic 
bouton after 3 h. This may seem contradictory at first as GFP-Liprin-α 2 has a higher 
proportion of cytoplasmic protein but possibly it could reflect the putative roles of 
these two active zone proteins. While Liprins-α are hypothesized to function as a 
scaffold and maintain the active zone structure and thus need to be robustly 
integrated in the proteinacous network at the active zone, RIM1α needs to be much 
more mobile to perform its role in priming of SVs. Most likely both proteins have two 
pools with different exchange rates, a slow pool reflecting the proteins integrated in 
the CAZ and a fast pool of unbound proteins as has been shown for three proteins, 
Basoon, Munc13 and synapsin I. These proteins also show very different dynamics 
(Fig. 6.1). For the large scaffolding protein Bassoon a time constant of >8h for the 
slow pool and a time constant of 5 min for the fast pool with a relation of 4:1 was 
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described (Tsuriel et al., 2009). In contrast much faster dynamics were reported for 
synapsin I, a molecule that is thought to link SV and the cytoskeleton. For synapsin I 
a time constant of the fast pool of 2.3 min and 87 min for the slow pool was observed 
(Tsuriel et al., 2006). Interestingly, the fraction of synapsin I belonging to the fast pool 
was activity dependent. About 30% of the protein belonged to the fast pool in 
unstimulated conditions while under stimulation the pool makes up about 50% of the 
protein. For Munc13, a protein involved in priming of synaptic vesicles, very similar 
time constants for the fast pool (3 min) as well as for the slow pool (80 min) were 
found (Kalla et al., 2006). To precisely define the time constants of Liprin-α2 and 
RIM1α and their possible dependence on activity more experiments would be 
required. 
 
Figure 6.1: Relative tenacity of active zone and synaptic vesicle proteins 
(A), Schematic drawing of SVs and selected AZ components. SV, synaptic vesicle. 
Modified from a figure by Noam Ziv. (B), Proteins are ordered from dynamic to stabil. 
A 
B 
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6.4 Disruption of Liprin-α function 
We pursued two approaches to study the functional role of Liprins-α, shRNAs to 
investigate the consequences of the loss of single or multiple Liprins-α and point 
mutations to study the effect of the disruption of specific interactions. 
So far, in contrast to C. elegans and Drosophila, there are no knockout mice for 
Liprins-α available. Our analysis of the expression of Liprins-α showed that all 
isoforms are present in all brain regions and in addition Liprin-α1 is also widely 
expressed outside the brain, e.g the lung and muscles, and is implicated to play a 
role in development. Therefore, it would be required to design conditional knockouts 
for all four isoforms and then cross quadruple knockouts to Cre-expressing mice. The 
analyses would require multiple generations of breeding which would be a very time 
consuming process. In addition, the knockout could be lethal early in development. 
We therefore decided to pursue an shRNA approach, which allows for studying the 
effect of a knock-down of single as well as combination of Liprin-α isoforms. Next to 
experiments in primary cell cultures using the rAAV virus as a method of shRNA 
introduction allows to study the effect of the knockdown in vivo by injecting the virus 
into either embryos or adult animals. Thus, this approach allows circumventing some 
of the problems of knockout animals like lethality, compensation or the cross 
breading of multiple mouse lines.  
Here, we could identify shRNAs against Liprin-α2 and -α3, the two major Liprin-α 
isoforms in the brain. This tool allows testing the role of Liprins-α in different 
processes like synapse maturation or maintenance using assays like the synapse 
maturation assay established in the Dresbach lab (Wittenmayer et al., 2009). It would 
also be interesting to analyze the effect of the knock down on the dynamics of Liprin-
α interaction partners using time-lapse imaging. 
As a second approach we aimed to identify point mutations to disrupt the interaction 
of RIM1α and Liprin-α as well as the Liprin-α homodimerization. The advantage of 
point mutations in comparison to a knockout approach is that in a knockout animal 
the missing protein can potentially be substituted by another protein. This could 
prevent a phenotype. When a point mutation is introduced the protein is still present 
but not functional e.g. in respect to a specific interaction. A point mutation in Rim1α 
effectively disrupting the interaction between Liprin-α2 and RIM1α could be 
identified. Other studies showed that point mutations can be an effective tool to 
  DISCUSSION 
 89 
delineate the role of specific interactions. Using a point mutation that disrupts the 
RIM1α-Munc13 interaction it was shown that RIM1α is critical for enrichment of 
Munc13 at the active zone (Andrews-Zwilling et al., 2006).  
We intend to employ the identified point mutation e.g. to characterize the role of the 
RIM1α-Liprin-α interaction using time-lapse imaging. In addition, we plan to identify 
further point mutations that disrupt other interactions to be able to characterize the 
role of different interactions in Liprin-α function.  
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Suppl. Fig. 1: Alignment of C. elegans (SYD-2), Drosophila (Dliprin), and mouse 
Liprins-α1-4.  
Sequences were aligned using T-coffee. Boxshade was used to create the alignment 
figure. Black boxes indicate identical amino acid residues and grey boxes mark 
similar residues. 
 
 
Suppl. Fig. 2: Alignment of the amino acid sequence of mouse Liprin-α1-4.  
Red boxes highlight the locations of the peptide sequence used for the generation of 
the isoform-specific antibodies. 
  
 
Suppl. Table 1 
 Exon-intron structure of the human Liprin-α1 (PPFIA1) gene 
Exon Nucleotide no.   Size Flanking  sequences    
1 69,794,471 - 69,794,668 198 agccgggccc GCTCCTCCT  GCGAGCAAG gtaagggagc 
2 69,795,926 - 69,796,190 264 tcatttcaag ATG ATG TGC  CTT CCA CAG gtatgagtgc 
3 69,848,156 - 69,848,257 102 gattttctag GAG TTC GCA  AAC ACC AGG gtgagtgtga 
4 69,848,600 - 69,848,765 165 tttatttcag CTG CTG TTA  GAT GAA AAG gtgccatcag 
5 69,849,254 - 69,849,328 75 ttattttcag GTG AGA GAG  CAC AAA GAG gtaagcttga 
6 69,850,016 - 69,850,117 102 ttgctttcag CTA ATG ATT  AGT GGA AAG gcaagtctgt 
7 69,850,351 - 69,850,572 222 cccctatcag AGA TCT TCT  GTC CGT GAA gtgagcaata 
8 69,853,927 - 69,854,073 147 cctaatttag GCC ATG GCC  CAT CGA CAG gtaatggatt 
9 69,855,714 - 69,855,848 135 cattttatag ACT GAA GAT  CTT TCC AAG gtagtgccat 
10* 69,856,776 - 69,856,850 75 ggctttgtag TCT GAC CTT  CTT AGG AAG gtagaatggg 
11 69,857,224 - 69,857,307 84 ctgctgacag GCT GAA GAG  CTG CAG CGG gtgagcatgc 
12 69,859,317 - 69,859,448 132 cctgctttag GCA AGG CAA  GAA GAT AAG gtaagttaga 
13 69,861,119 - 69,861,181 64 cttttttcag AAC TCT CTT  CAC GAT AAG gtactgaaat 
14 69,862,128 - 69,862,207 79 ttttctgtag GAT CAG CTT  CTT CAT CAT GG gtatggtatt 
15 69,862,925 - 69,863,060 136 catgtttcag C CGA CCC CAC  CCT TCC AAG gcaaggtctt 
16 69,867,423 - 69,867,646 224 ttgtttatag GTA CAA ACT  AAA GAG ATC AG gtgtgtgcaa 
17 69,871,943 - 69,872,174 232 tttattttag G TTG ATT CAG  ATG ACC CTT gtacgtatcc 
18* 69,874,748 - 69,874,777 30 catctatcag CCT AGT GAT  CGT AGA AAG gtaaattgtt 
19 69,878,055 - 69,878,206 152 cacccctcag TTG CCA CCT  GAC ATA AGG AA gtaaggagcc 
20 69,879,393 - 69,879,565 173 ttcctcgaag C TCC ACA GGC  TTA GGA CAA G gttggttggt 
21 69,879,915 - 69,880,008 94 ttcctcacag CT GGT GTT TCC  CTT CAA AAA AA gtaagctttg 
22 69,885,849 - 69,885,930 82 tcctttatag G CAT GAA TTG  TGG CTA GAG gtacatcctt 
23 69,886,042 - 69,886,242 201 ccgcctccag CTC TGG GTT  TCT AGA ACG gtacgttcag 
24* 69,889,127 - 69,889,189 63 gtcaccttag ACC ACA GGA  CCG CAA ACG gttagtcacg 
25* 69,889,695 - 69,889,721 27 gtaaccccag GAA GAT GAG  TGG GCT CAG gttggagtct 
26a 69,895,963 - 69,896,144 176 ttatgaaaag CAG ACA CTC  AGT TTT CAC AG gtaacttaat 
26 69,895,966 - 69,896,144 173 tgaaaagcag ACA CTC GCC  AGT TTT CAC AG gtaacttaat 
27 69,896,231 - 69,896,328 98 ttccaaatag A AAC AGT TTC  GAA ATA AAA G gttagtacat 
28 69,898,672 - 69,898,847 176 tcttttgcag AC GTG CTT GTT  AAC ACA CAG gtgacgccaa 
29 69,900,286 - 69,900,354 69 gttatttcag GCT CGT GCT  TTT GAT GAA gtaagttttt 
30 69,901,784 - 69,901,949 166 aatttaccag GAT GAT GAT  AGA TGG ACG gtatgtgatg 
30b 69,901,784 - 69,902,146 363 aatttaccag GAT GAT GAT  TGA TGGGTC aaaacacgct 
31* 69,905,842 - 69,905,911 71 gttgaaacag  GCA ATG TAT  TAA AGTCTCCTGTTG gtgagtagag 
32 69,906,757 - 69,908,511 1394 tattttccag TTT ACC CAC  
TGA TTATGCAGCA... 
CACTGCTCA caaaggtggc 
          
Data are based on the analysis of human genome sequences in the NCBI, Ensembl and UCSC databases. Nucleotide numbers 
correspond to thoses of the assembled UCSC genome.  
*Exons that are subject to alternative splicing. 
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Suppl. Table 2 
 Exon-intron structure of the mouse Liprin-α1 (PPFIA1) gene 
Exon Nucleotide no.   Size Flanking  sequences    
1 151,739,634 - 151,739,346 198 ccgacgcgcc GGACGTCGG  CCGGCCAAG gtgagggcgg 
2 151,738,438 - 151,738,185 264 gccggccaag ATG ATG TGC  CTT CCA CAG gtatgcccat 
3 151,706,966 - 151,706,865 102 cactctctag GAG TTT GCT  AAC ACT AGG gtcagtcact 
4 151,706,694 - 151,706,530 165 tctgttgcag CTG CTG TTG  GAT GAG AAG gtacaatcac 
5 151,705,955 - 151,705,881 75 tcacttgcag GTA CGA GAG  CAC AAA GAG gtaagcttgg 
6 151,705,551 - 151,705,450 102 tcttttgtag CTA ATG ATT  AAC GGC AAG gcaagtcctt 
7 151,705,272 - 151,705,054 222 tgcttttcag AGA TCT TCT  GTC CGT GAA gtgagtgcgg 
8 151,703,651 - 151,703,505 147 tccaacacag GCA ATG GCC  CAC CGA CAG gtactggggt 
9 151,702,025 - 151,701,891 135 ccctttctag ACA GAA GAC  CTC TCC AAG gtgcgcctgg 
10* 151,700,851 - 151,700,778 75 tgctttatag TCT GGT CCT  CTT AGG AAG gtagaattgt 
11 151,700,429 - 151,700,346 84 ttaccggcag GCT GAG GAG  CTG CAG CGG gtatgtatgg 
12 151,699,282 - 151,699,251 132 tctgttttag GCA AGG CAG  GAG GAC AAG gtgagcagat 
13 151,696,841 - 151,696,778 64 tctttttcag AAT TCT CTA  CAT GAT AAG gtacctcact 
14 151,696,266 - 151,696,187 79 tgttttctag GAC CAA CTT  CTC CAT CAT GG gtatggcggt 
15 151,694,169 - 151,694,034 136 catgtttcag C CGA CCC CAT  CCC TCC AAG gcaaggcctc 
16 151,692,199 - 151,691,977 224 ttgttggtag GTG CAG ACC  AAA GAG ATC AG gtatatatct 
17 151,691,039 - 151,690,808 232 tgtattttag G CTG ATA CAA  ATG ACT CTG gtaagtgggg 
18* 151,688,801 - 151,688,772 30 catctgtcag CCT AGT GAC  CGG AGA CAG gtaaatcatt 
19 151,686,308 - 151,686,157 152 ttgctctcag TTG CCA GCT  GAC CTG AGG AA gtaaggagcg 
20 151,684,784 - 151,684,612 173 ttccttaaag C TCC ACA GGC  CCA GGG CAA G gttggtaggt 
21 151,684,295 - 151,684,202 94 ttccttgtag TT GGT GTT TCA  CTT CAG AAA AA gtaagctgct 
22 151,677,728 - 151,677,647 82 tccctcatag G CAC GAG CTG  TGG TTA GAG gtgagtcctc 
23 151,677,557 - 151,677,357 201 tcatgtctag CTC TGG GTT  TCC AGG ACG gtaagtctcc 
24* 151,675,164 - 151,675,102 63 ggtaccttag ACC ACA GGA  CCA CAA ACG gttagtcact 
25* 151,674,625 - 151,674,596 30 gtaacatcag GAA GAC GAG  TGG GCT CAG gttggcatct 
26a 151,671,110 - 151,670,938 176 ttactaaaag CAG ACT CTA  AGC TTC CAC AG gcaagtgctc 
26 151,671,113 - 151,670,938 173 ctaaaagcag ACT CTA GCA  AGC TTC CAC AG gcaagtgctc 
27 151,670,846 - 151,670,749 98 ttgtaaacag A AAC AGT TTC  GAG ACA AGA G gtgagttccc 
28 151,668,340 - 151,668,165 176 tctcttgcag AT GTG CTT GTG  AAT ACG CAG gtgaccccag 
29 151,667,684 - 151,667,616 69 actgttttag GCT CGA GCT  TTT GAT GAG gtaagtggat 
30 151,667,155 - 151,666,990 166 ggtttgctag GAT GAT GAC  AGA TGG ACG gtatgtggtg 
31* 151,665,002 - 151,664,932 71 gtggagacag  GTA GTG TGT  TAG AGCCTCCTGCTG gtgagtagag 
32 151,663,894 - 151,662,660 1394 ttacttgcag TTT ACC CAC  
AGA TGA CGT 
...CCTGCCAGTT aagagtgctg 
          
Data are based on the analysis of human genome sequences in the NCBI, Ensembl and UCSC databases. Nucleotide numbers 
correspond to thoses of the assembled UCSC genome.  
*Exons that are subject to alternative splicing. 
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Suppl. Table 3 
 Exon-intron structure of the human Liprin-α2 (PPFIA2) gene 
Exon Nucleotide no.   Size Flanking  sequences    
1 80,676,564 - 80,676,310 254 ccgttgctag GGAAATGGT  AGACATTAG gtacagaagc 
2 80,672,133 - 80,671,883 248 tttctttaag CA ATG ATG TGT  CTG CCA CAG gtatgcttcc 
3 80,594,754 - 80,594,701 54 cccttttcag GAT ATC GAA  GAT CCA CCG gtaagttaga 
4 80,375,776 - 80,375,675 102 acttttccag GAA TTT GCT  AAC ACA AGA gtaagtgtaa 
5 80,363,630 - 80,363,466 165 aacccaatag CTA TTA CTG  GAT GAA AAG gtatagtatg 
6 80,357,956 - 80,357,882 75 tttcttctag GTA AGG GAG  AAT CAG GAG gtaacctgcc 
7 80,323,813 - 80,323,697 117 tattttgcag ATT GTT GCC  CAT GAG AAG gtatgacaca 
8 80,302,154 - 80,301,933 222 atttctgcag CGT TTG TCC  ATT AGG GAG gtaagtgatt 
9 80,293,852 - 80,293,706 147 ttaattgtag GCC ATG GCA  CTG CGG CAG gttcagtatc 
10 80,292,678 - 80,292,544 135 cccatttcag ATG GAA GAG  CTA ACC AAG gtactgcact 
11 80,287,104 - 80,287,021 84 ttcttaacag GCT GAA GAG  CTT CAA AGA gtatgtatat 
12 80,286,766 - 80,286,635 132 aaaatgtaag GCT AGG CAA  GAA GAA AAG gtaaaacgat 
13 80,285,080 - 80,285,018 63 ttttctttag AAT GTT TTA  CAT GAT AAG gtataatgga 
14 80,280,694 - 80,280,603 92 gattttttag GAA AGA TTA  ACA ATA CCA AG gtaacattaa 
15 80,276,127 - 80,275,992 136 ttttttccag A ACT CAT CTA  GAG CCA AAG gttaatcttt 
16 80,271,249 - 80,271,029 221 caccattcag GTG AAA TCT  AAA GAA ATC AG gtaacttcaa 
17 80,265,680 - 80,265,443 238 tatctttcag G CTA ATT CAG  ATG ACA CTG gtatggtgat 
18* 80,262,603 - 80,262,574 30 ccaatcacag CCA AGT GAT  CGG AGA AAG gtacagtaaa 
19 80,259,118 - 80,258,988 131 ttgcttctag ATT GCA GTT  GAT GCT CGA AG gtaagactct  
20 80,257,244 - 80,257,090 155 tgttttgcag T AGT TTA TCT  GGG CAG CTC C gtaagtatgc 
21 80,243,780 - 80,243,687 94 ctcttcacag GA GGC TTT ATG  CTA AAG AAA AA gtaggtttgg 
22 80,217,292 - 80,217,211 85 tatacttcag G CAT GAA CTT  TGG CTA GAG gtaagagaat 
23 80,212,945 - 80,212,745 201 tatctaacag CTT TGG TTG  TCT CGA ACT gtgagtcagt 
24* 80,202,213 - 80,202,151 63 tcctcactag CCT TCA GGC  GCA AAA ACG gttagtctta 
25* 80,200,949 - 80,200,920 30 gctaacacag AAA GAA TCT  TGG GCC CAG gtaggagatt 
26a 80,199,360 - 80,199,167 194 acaattctag TGT CCG GTT  AGT TTC CAT CG gtaggtgttt 
26 80,199,342 - 80,199,167 176 ttttctacag ACC CTG GCT  AGT TTC CAT CG gtaggtgttt 
27 80,195,324 - 80,195,227 98 aaaaaaaaag A ACA AGT TTA  GAA ATA AAA G gtaatatatc 
28 80,185,997 - 80,185,805 193 cttttcctag AC TGT TTG GTG  AAC ACC CAG gcaagtcact 
29 80,184,925 - 80,184,862 64 acgtcaacag GCA AGG CAG  CTG GAT GAA gtaagtccac 
30 80,181,300 - 80,181,141 160 gtactggcag AGT GAT GAC  ACA ACA GAT G gtacagtagt 
31 80,179,950 - 80,179,859 92 ccatttgcag TT GCT TCA TCA  
TGT TGA CCA... 
TGACCTGCT gtgagtagtt 
32 80,177,570 - 80,175,914 1657 tatattttag ATGGCGTCCT  ATATAGGAA  
          
Data are based on the analysis of human genome sequences in the NCBI, Ensembl and UCSC databases. Nucleotide numbers 
correspond to thoses of the assembled UCSC genome.  
*Exons that are subject to alternative splicing. 
 
                
 
 
 
 
 
 
 
 
     APPEN
D
IX 
95 
  
 
Suppl. Table 4 
 Exon-intron structure of the mouse Liprin-α2 (PPFIA2) gene 
Exon Nucleotide no.   Size Flanking  sequences    
1 105,907,395 - 105,907,647 252 ccgttgctag GGAAATGGT  AGACATTAG gtacagaagc 
2 105,911,687 - 105,911,938 251 tttctttaag CA ATG ATG TGT  CTA CCT CAG gtacgagtct 
3 105,994,303 - 105,994,355 54 ccctttccag GAC ATC GAA  GAT CCA CCG gtaagttaga 
4 106,180,543 - 106,180,644 102 ccacttctag GAG TTT GCT  AAC ACA AGA gtatgtatta 
5 106,199,044 - 106,199,203 165 gatcccacag CTG TTA CTG  GAT GAA AAG gtatcgtaca 
6* 106,204,530 - 106,204,604 75 tttcttctag GTA AGG GAG  AAT CAG GAG gtaacacacc 
7 106,237,793 - 106,237,909 117 tatttttcag ATT GTT GCC  CAT GAA AAG gtatgatgca 
8 106,256,392 - 106,256,623 222 cttcctgcag CGT CTA TCC  ATC CGA GAG gtaggtagct 
9a 106,265,933 - 106,266,091 159 acctttacag TGT TAT TTA  TTG CGG CAG gttcagtatc 
9 106,265,945 - 106,266,091 147 ttatttacag GCC ATG GCT  TTG CGG CAG gttcagtatc 
10 106,267,622 - 106,267,756 135 cccatttcag ATG GAA GAA  CTA ACA AAG gtactgcact 
11 106,272,752 - 106,272,835 84 tccttaacag GCT GAA GAG  CTT CAA AGA gtatgcatga 
12 106,273,108 - 106,273,239 132 taactataag GCT AGA CAA  GAA GAG AAG gtacagtctc 
13 106,274,336 - 106,274,399 63 ttttccatag AAT GTT TTG  CAT GAT AAG gtatcatgga 
14 106,279,743 - 106,279,833 92 ttatttttag GAA AGA TTA  ACT ATA TCA AG gtaacattac 
15 106,291,993 - 106,292,128 136 tgtttttcag A ACT CAT ATA  GAA CCA AAG gtgattgctt 
16 106,294,465 - 106,294,685 221 cattattcag GTG AAA TCC  AAA GAA ATA AG gtatcgatac 
17 106,295,217 - 106,295,454 238 tatcttctag A CTA ATT CAA  ATG ACC CTG gtatgattat 
18 106,296,833 - 106,296,862 30 cccttaacag CCA AGT GAT  CGG AGA AAG gtaatgtaaa 
19 106,300,309 - 106,300,440 131 ctatttctag ATT GCA GTG  GAT GCC CGG AG gtaaggctca 
20a 106,302,303 - 106,302,457 155 tgttttgaag C AGT TTA TCT  GGG CAG CTT C gtaagtatgg 
20 106,302,306 - 106,302,457 152 tttgaagcag T TTA TCT GCC  GGG CAG CTT C gtaagtatgg 
21 106,306,935 - 106,307,028 94 ttctccacag GA GGC TTC ATG  CTG AAG AAA AA gtaggtttgg 
22 106,330,487 - 106,330,569 82 tgtacttcag G CAT GAA CTT  TGG CTG GAG gtaagcaaaa 
23 106,333,374 - 106,333,574 201 aatacaacag CTC TGG CTG  TCG CGT ACT gtgagtcaat 
24 1063,406,99 - 106,340,761 63 ctctcattag CCT TCA GGC  GCA AAA ACG gttagtcttt 
25 106,341,873 - 106,341,902 30 gctaacccag AAA GAA TCT  TGG GCC CAG gtaggaaact 
26a 106,343,422 - 106,343,615 194 acaattccag TGT CCG GTT  AGT TTC CAT CG gtaggttgtg 
26 106,343,440 - 106,341,902 176 ttttctacag ACC CTG GCT  TGG GCC CAG gtaggaaact 
27 106,344,769 - 106,344,866 98 atgaaaatag A ACA AGT TTA  GAA ATA AAA G gtacatgccc 
28 106,350,621 - 106,350,796 176 cttttcctag    AT GGT TTA GTG   AAC ACC CAG gcaagcatgc 
29 106,352,737 - 106,352,805   69 atgttaacag GCA AGG CAG   CTG GAT GAA gtaagttctt 
30 106,364,759 - 106,364,918 160 gtactggcag AGT GAC GAC  ACG ACA GAC G gtacagtagt 
31 106,366,110 - 106,366,201 92 tcatttgcag TT GCT TCA TCA  
TGT TGA CAA... 
TGACCTGCT gtgagtagtt 
32 106,368,179 - 106,370,502 2324 cccctttcag ATGTCATCT  CTTTTGGCG aataaaacaa 
          
Data are based on the analysis of human genome sequences in the NCBI, Ensembl and UCSC databases. Nucleotide numbers correspond 
to thoses of the assembled UCSC genome. *Exons that are subject to alternative splicing. 
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Suppl. Table 5 
 Exon-intron structure of the human Liprin-α3 (PPFIA3) gene 
Exon Nucleotide no.   Size Flanking  sequences    
1 54,314,475 - 54,314,791 317 tggggggaag GTGGGATTT  ACCAGGCAG gtaagagccc 
2 54,322,928 - 54,323,182 255 cgccccgcag 
GCCCGCACCG 
... GCC ATG ATG  CTG CCC CAG gtctgggcgg 
3 54,323,436 - 54,323,537 102 gtctggacag GAG TTT GCA  AAC ACG CGG gtgaggggtg 
4 54,323,917 - 54,324,081 165 gtgcttgcag CTC CTC CTG  GAT GAG AAG gtatgagaat 
5 54,324,449 - 54,324,523 75 cgatccccag GTC CGG GAG  AAT CAG GAG gtgtgggtgt 
6 54,325,062 - 54,325,136 75 acacttccag ACT CTG AAC  GAT GGG CAG gtgagacatg 
7 54,325,447 - 54,325,668 222 ctcactccag ACT CTT GCC  CTC AAG GAG gtgaggcccc 
8 54,328,070 - 54,328,216 147 acctccgcag GCG CTG GCG  TAT CGG CAG gtgggggcgc 
9 54,328,306 - 54,328,440 135 cctcccccag AGT GAA GAG  CTC AAC AAG gtgcggggag 
10 54,328,865 - 54,328,948 84 catctcctag GCC GAG GAA  CTG CAG CGG gtgagggggc 
11 54,329,103 - 54,329,234 132 ctttgcgcag GCC CGG CAG  GAG GAG AAG gtgcgccccc 
12 54,329,708 - 54,329,770 63 gtctccacag AAC TCC CTG  CTA AAC AAG gtagggggcc 
13 54,329,905 - 54,329,984 80 cggcccccag GAG CAG CTC  TCC TAC TCC AG gtgacagcag 
14 54,330,848 - 54,330,992 145 atgcccacag G TCT CTC CCT  CCC TCC AAG gtcagcagct 
15 54,331,793 - 54,331,980 188 acagggatag GAT TGG GAG  AAG GAG ATC AA gtgagccctg 
16 54,333,274 - 54,333,496 223 ccctcctcag G CTG ATC CAA  GAC AAG GCT gtgagtgctc 
17 54,334,737 - 54,334,900 164 ctgtcctcag AAT CAT GTC  CCA CGG GGA AG gtcagcaggg 
18 54,335,030 - 54,335,157 128 tgctttcccag T GAG GGC ACC  TCT TCT CTG G gtgagtacct 
19 54,336,489 - 54,336,582 94 ctgcctccag CT GGA ACA CCC  AAC AAG AGG AA gtgagtgtgt 
20 54,337,103 - 54,337,184 82 acccttacag G CAT GAA CTC  TGG CTG GAG gtactggggc 
21 54,337,873 - 54,338,073 201 tccgctgcag CTG TGG GTG  TCC CGC ACT  gtgagtgtcc 
22 54,341,012 - 54,341,074 63 tgcccctcag TCC ACA GGA  ACC AAG CCC gtgagtgccc 
23* 54,341,235 - 54,341,261 27 aacgggtcag GAG ACC AAG  TGG GAG CAG gtagggggcg 
24 54,343,152 - 54,343,327 176 atggccccag ATC CTG GCA  AGC TTT CAC AG gtgggggctg 
25 54,343,735 - 54,343,831 98 tgctgctcag G GTG AGT CTA  CAG ATC CGA G gtgagtagag 
26 54,344,0662 - 54,344,237 176 ccgtccccag AC GTG ATG GTG  AAT GCA CAG gtgagctgcc 
27 54,344,326 - 54,344,394 69 ctctttccag GCC CGG CAG  CTG GAC GAG gtgggcgcgg 
28 54,344,616 - 54,344,787 172 ctatacctag GAC AGC GCC  CAG CCA GAA G tggggggct 
29 54,345,149 - 54,345,220 72 tctccctcca GC CAG ACT TCT  
TGC TAG 
TGCAGGCCTCCAG gtgaggaccg 
30 54,345,305 - 54,346,090 786 cgtcatgcag GTGACCTCA  AACTGTTTC aaaaagcttc 
          
Data are based on the analysis of human genome sequences in the NCBI, Ensembl and UCSC databases. Nucleotide numbers correspond 
to thoses of the assembled UCSC genome.  
*Exons that are subject to alternative splicing. 
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Suppl. Table 6 
 Exon-intron structure of the mouse Liprin-α3 (PPFIA3) gen 
Exon Nucleotide no.   Size Flanking  sequences    
1 52,622,296 - 52,621,29 268 cctggatctg GCGACTGCG  GCGGACCAG gtaggtaaga 
 
2 52,617,192 
 
- 52,616,935 
 
255 gtacccgcag 
GCCGGCACCG...  
ATG ATG TGC  CTG CCT CAG gttgggcggg 
3 52,616,007 - 52,615,906 102 gcctggacag GAG TTT GCG  AAC ACC CGG gtgagggccg 
4 52,615,594 - 52,615,443 165 atccttccag CTC CTT CTG  GAT GAG AAG gtaggagagt 
5 52,614,711 - 52,614,637 75 cggtctgcag GTC CGG GAA  AAT CAG GAG gtaggggcgg 
6 52,614,232 - 52,614,158 75 actcttctag GCC CTG AAC  GAT GGA CAG gtgagagtct 
7 52,613,350 - 52,613,129 222 ctctctccag ACC CTT GCC  CTC AAG GAG gtgaggcgga 
8 52,612,057 - 52,611,911 147 acctcttcag GCC CTG GCT  TAC AGA CAG gtgaaagccc 
9 52,611,814 - 52,611,680 135 tctctcccag AGT GAA GAG  CTG AAC AAG gtgacagcct 
10 52,611,591 - 52,611,506 84 tgtccactag GCT GAG GAA  CTG CAG CGG gtgagagggc 
11 52,610,660 - 52,610,529 132 ctttgttcag GCC CGG CAG  GAG GAG AAG gtgcgccccc 
12 52,610,299 - 52,610,237 63 gtccccacag AAC TCA CTG  CTG AAT AAG gtgaggaccc 
13 52,610,148 - 52,610,067 80 ctctccacag GAG CAG CTC  TCC TAT TCC AG gtgacagaag 
14 52,609,033 - 52,608,889 145 gtgctcacag G TCC CTT CCT  TCT TCC AAG gtcagtagcc 
15 52,607,645 - 52,607,457 188 tacaggacag GAC TGG GAT  AAG GAA ATC AA gtgagtccta 
16 52,605,661 - 52,605,439 223 cctcttccag G CTA ATT CAA  GAC AAG ACC gtgagtactc 
17 52,603,995 - 52,603,832 164 ctgtccccag AAC CAT GTC  CCC CGG GGA AG gtaggcagaa 
18 52,603,739 - 52,603,612 128 gtgtctctag T GAG AGC ACC  GTT TCT CTG G gtgagtacta 
19 52,603,190 - 52,603,096 94 ctgccaccag CC GGG ACA CCC  AAC AAG AGG AA gtgagtgtcc 
20 52,602,875 - 52,602,794 82 tctctgctag G CAC GAA CTT  TGG CTG GAG gtattctgac 
21 52,602,302 - 52,602,102 201 gtgacctcag CTC TGG GTG  TCA CGC ACT  gtgagtgccc 
22 52,602,173 - 52,599,111 63 cgcccttcag CCC ACA GGA  ACA AAA CCC gtgagtgcct 
23* 52,598,949 - 52,598,923 27 aacgggtcag GAG ACC AAG  TGG GAG CAG gtaggggtgc 
24 52,597,871 - 52,597,696 176 atggccccag ATC CTG GCA  AGC TTC CAC AG gtgggggctg 
25 52,597,154 - 52,597,057 98 cactgctcag G GTT AGT CTG  CAA ATC AGA G gtgaggtccc 
26 52,596,615 - 52,596,438 176 tcttctccag AC GTG ATG GTG  AAT GCA CAA gtgagctttg 
27 52,596,338 - 52,596,208 69 tcttttccag GCT CGG CAA  CTG GAT GAG gtgggcgtgg 
28 52,596,116 - 52,595,945 172 gtacatctag GAC AGT GCC  CAG CCT GAA G gtaagggact 
29 52,595,630 - 52,595,559 72 ctctctccag GC CAG ACT TCT  
TGC TAG 
TGTGCACCTCCAG gtgagtactc 
*30 52,595,450 - 52,594,492 9 tcaatgaaag TGACCTCAT  CACCAGTCC tagcttttgt 
  -        
Data are based on the analysis of human genome sequences in the NCBI, Ensembl and UCSC databases. Nucleotide numbers correspond 
to thoses of the assembled UCSC genome.  
*Exons that are subject to alternative splicing. 
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Suppl. Table 7 
 Exon-intron structure of the human Liprin-α4 (PPFIA4) gene 
Exon Nucleotide no.   Size Flanking  sequences    
1 201,274,361 - 201,274,993 
 
tttcccacag 
ACACACTGCC... 
ATG TGT GAG  CTC CCC CAG gtaaggcccg 
2 201,279,148 - 201,279,249 102 gggttttcag GAA TTT GCC  AAC ACA CGG gtaagtgggg 
3 201,279,682 - 201,279,846 165 tccctgccag CTG CTT CTG  GAT GAG AAG gtgcccacct 
4 201,280,130 - 201,280,204 75 cctcgagcag GTG CGA GAG  CAC CAG CAG gtaatctgcc 
5 201,280,447 - 201,280,536 90 tgccctacag GTA ATC TGC  CTG TGG AAG gtaggtcatg 
6 201,281,119 - 201,281,310 192 atccctggag GAG GAT ACG  CTC CGG GAG gtgcgtgagg 
7 201,281,592 - 201,281,738 147 cttctcccag GCT CTG GCC  CAC CGC CAG gtacctcctc 
8 201,281,999 - 201,282,137 139 acattgctag TGT GAG GAG  CTC ACC AAG gcaagtgggc 
9 201,283,985 - 201,284,061 77 ctgcccctag GCT GAA GAA  CTG GCA CGG gtgagggcac 
10 201,284,334 - 201,284,465 132 ggctgtgcag GTG CGC CAG  GAG GAG AAG gtgcccagag 
11* 201,284,669 - 201,284,731 63 tctcccccag AAC ACG TTG  CAC CAC AAG gtacccggct 
12 201,285,427 - 201,285,518 92 gctggcacag GGC CGC CTG  GTC CAC TCC AG gtactgcagc 
13 201,287,519 - 201,287,628 109 accgctcaag G TCG CAC ATG  TCT GCC AAG gtgagggggt 
14 201,289,504 - 201,289,712 209 ctttgctaag GAC TGG GAG  GAG GAA ATC AG gttagggcag 
15 201,291,183 - 201,291,423 241 tcccttccag G ATG ATT CAG  ATG ACC CTG gtgagaggca 
16 201,291,871 - 201,291,906 36 tcccttccag CCC AGT GAC  AAG CTG CTG gtgagaggca 
17 201,292,125 - 201,292,259 134 gtctgttcag TCG CCA GTG  GAA GGC AAG AG gtaagtagag 
18 201,292,235 - 201,292,725 193 caccctgtag T GCC TTG GAG  CCT AAC GGA G gtctgggcgg 
19 201,294,929 - 201,295,022 94 ttccttgtag TT CTG CTA ACA  CTA AAG AAG AA gtaagagcca 
20 201,295,521 - 201,295,602 82 ttcctataag A CAC CAG CTG  TGG TTG GAG gtaagcctga 
21 201,295,968 - 201,296,168 201 gtgtctgcag CTC TGG GTG  TCC AGG ACT gtgagtggcc 
22 201,296,721 - 201,296,783 63 ctgcctgcag TCT TCT GGG  ACT AAA ACA gtgagtctgg 
23* 201,297,403 - 201,297,429 27 ttcctgctag GAC AGT GAG  TGG GCT CAG gtaagactcc 
24 201,299,579 - 201,299,754 176 atttccctag ACC CTG GCC  AGC TTC CAT CG gtgagcgcgg 
25 201,303,446 - 201,303,543 98 gtgcctgcag A ACC AGT CTT  GAG ATC AAG G gtaagctcgt 
26 201,304,204 - 201,304,379 176 cacactccag AT GTG TTA GTC  AAC ACC CAG gtgggcagcc 
27 201,307,443 - 201,307,511 68 tggactgcag GCA CGC CAA  AAG CTG GAT GA gtgagtacct 
28 201,311,328 - 201,311,508 181 catggtgcag G GGG ATG ACA  ATG CCT GAA G gtgagtaaca 
29* 201,311,719 - 201,311,827 109 cttctcccag CT GGG ACG GCG  TGA... GTGGCTCGGG gtaagtgggc 
30 201,312,092 - 201,314,487 2396 tctccctcag CTC ACT CCC  
GAC TAG CCA... 
AGACAATGTA caaatggcct 
          
Data are based on the analysis of human genome sequences in the NCBI, Ensembl and UCSC databases. Nucleotide numbers correspond 
to thoses of the assembled UCSC genome.  
*Exons that are subject to alternative splicing. 
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Suppl. Table 8 
 Exon-intron structure of the mouse Liprin-α4 (PPFIA4) gene 
Exon Nucleotide no.   Size Flanking  sequences    
 
1 136,229,505 
 
- 136,228,868 
 
639 tctcccacag 
ACCACATGTG... 
ATC ATG TGT  CTT CCC CAG gtaaggttcc 
2 136,225,824 - 136,225,723 102 gggctttcag GAA TTT GCC  AAC ACA AGG gtaagtaagg 
3 136,225,385 - 136,225,221 165 tctctcccag CTG CTT CTG  GAT GAG AAG gtacccacct 
4 136,224,944 - 136,224,870 75 tcctgggcag GTG CGA GAG  CAC CAG CAG gtaagctgca 
5 136,224,666 - 136,224,577 90 tgtcttacag GTA TCT GCC  CTG TGG AAA gtgggtaatg 
6 136,224,026 - 136,223,835 192 gtccctggag GAT GAC ACT  CTC CGA GAG gtaggcgagg 
7 136,223,539 - 136,223,393 147 ctccgcccag GCT CTG GCT  CAC CGC CAG gtaacgcggc 
8 136,223,195 - 136,223,161 135 gtactgctag TGT GAG GAG  CTC ACC AAG gcaagtgggc 
9 136,221,171 - 136,221,088 84 ctgcacctag GCT GAG GAA  CTG GCA CGG gtgagggcac 
10 136,220,787 - 136,220,656 132 ggatgtgcag GTG CGC CAG  GAG GAG AAG gtgaggaagc 
11 136,219,670 - 136,219,579 92 cctggcacag G GCC GTC TGT  TCC ACT CCA G gtactagagt 
12 136,217,746 - 136,217,638 109 gtcactcaag G TCA CAC GTG  TCT GCC AAG gtaaggggtg 
13 136,216,000 - 136,215792 209 ctttgctaag GAC TGG GAG  GAG GAA ATC AG gtggggtggg 
14 136,214,625 - 136,214,385 241 ttctgagcag G ATG ATC CAG  ATG ACC CTG gtgagtctgg 
15 136,214,050 - 136,214,015 36 tctctttcag CCC AGC GAC  AAG CTG CTG gtgagtgctt 
16 136,2137,73 - 136,213,641 134 gtctgttcag TCG CCA GTG  GAG GGC AAG AG gtgagtgagc 
17 136,213,355 - 136,213,192 164 catcctgtag T GCC TTG GAG  CCT AAC GGA G gtctctgcct 
18 136,210,300 - 136,210,205 94 tcatttccag TT CTG CTA ACA  CTA AAG AAG AA gtaagagcct 
19 136,209,745 - 136,209,664 82 ctcccccaag A CAC CAG CTG  TGG CTG GAG gtgagcctgg 
20 136,209,313 - 136,209,114 201 atgtctgtag CTC TGG GTG  TCC AGG ACT gtgagtagcc 
21 136,208,696 - 136,208,634 63 ctgcctgcag TCT TCA GGG  ACC AAA ACA gtgagtctgc 
22 136,208,132 - 136,208,106 27 ctcctgctag GAC AGT GAG  TGG GCC CAG gtaagacccc 
23 136,206,328 - 136,206,153 232 atgtccccag ACC CTG GCC  AGT TTC CAT AG gtgagccagg 
24 136,200,961 - 136,200,864 98 gtgtctgcag A ACC AGT CTT  GAG ATC AAG G gtaaggttgc 
25 136,200,357 - 136,200,182 176 tgtcctccag AT GTG CTG GTC  AGC ACC CAG gtagccctca 
26 136,197,115 - 136,197,047 69 tgggtttcag GCC CGC CAA  AAT TGG ATG AC gtgagtacct 
27 136,196,045 - 136,195,868 178 cttggtgcag G GAG AAG AGA  ATG CCG GAA G gtgagtgcca 
28* 136,195,713 - 136,195,603 111 ctcctgccag CC GGG ACG GCG  
TGA CCCACCCCCC... 
CCGGCTCGGG gtaagtgggc 
29 136,195,405 - 136,193,360 2046 tctctcatag CTC ACT CCC  
GAC TAG CCCTTCC... 
AGACAATGTA caaatggtgt 
          
Data are based on the analysis of human genome sequences in the NCBI, Ensembl and UCSC databases. Nucleotide numbers correspond 
to thoses of the assembled UCSC genome.  
*Exons that are subject to alternative splicing. 
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Suppl. Table 9 
Human Liprin-α transcript variants produced by alternative splicing 
 
Gene Ensembl transcript ID Tigr Gene Indices GenBank entry number 
Liprin-α1       
10 - - BX648037  
Δ10  ENST00000253925, 
ENST00000389547 
THC2610455,  
THC2466389a 
DQ892401, NM_177423a 
18  - THC2655239,  
THC2652008a 
BM724097, BG772359a 
Δ18  ENST00000253925, 
ENST00000389547 
DB074051, 
THC2664979a 
DB256381, DB093696a 
24+25 - THC2652008, BF115477, AW003540a 
Δ24+25  ENST00000253925, 
ENST00000389547 
THC2664979,  
THC2610455a 
DA601551, BP288948a 
30b ENST00000389547 THC2661071 NM_177423, U22815a 
31 - THC2623316,  
THC2620206a 
AK124621, AK123331a 
Δ31 - THC2789153  CB963045a 
Liprin-α2       
6 ENST00000333447 THC2521513, 
DA097453a 
 XM_001088683, XM_001088353a 
Δ  6  - THC2512280  - 
23 ENST00000333447 THC2478562, 
THC2533874a 
NM_003625,  AB210009a 
Δ23  - AB173244, XM_509243a 
24 ENST00000333447 THC2478562, 
THC2533874a 
NM_003625,  AB210009a 
Δ24  DA175569, 
THC2489420 
BC104912, DA175569 
23+24 ENST00000333447 THC2478562, 
THC2533874a 
DA171009, NM_003625 
Δ23+24   DA365677, 
THC2515077 
DA365677, AK123372 
Liprin-α3       
23 ENST00000334186 THC2464523 BC10152,  BC101518a 
Δ23  ENST00000334329 THC2610653 DB022704, BU931579a 
Liprin-α4       
11  - -  DC308173, EG328335 
Δ11 ENST00000367238, 
ENST00000367240 
 -  - 
23 ENST00000367238, 
ENST00000367240 
NP1247464, 
THC2473050 
BC132923, BC132925a 
Δ23 ENST00000295706  THC2602563 AK023365, AF034801a 
29  - THC2760377, 
THC2602563 
DA199274,AK170782 
Δ29 ENST00000367238, 
ENST00000367240a 
THC247305 BC132925, BC132923a 
Data are based on the anaylsis of EST sequences in the UCSC, GenBank, ENSEMBL, and TIGR databases. Δ  marks 
variants, in which the exon is absent. a, databases contain additional EST sequences for this transcript variant. 
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Suppl. Tabel 10 
Alternative splicing of mouse Liprin-α1-4 
Gene Ensembl transcript ID Tigr Gene Indices GenBank entry number 
Liprin-α1    
10 - - - 
Δ10 - TC1612279, 
BG171917 
XM_133979, XM_918243 
18 - - DT917865, CF740050a 
Δ18 - TC1600458 - 
24 - - - 
Δ24 - CB519424 - 
25 - - - 
Δ25 - TC1707207 - 
24+25 - - - 
Δ24+25 - CB519424 CX201127, CF733114a 
31 - TC1600458 CX239318, CN702858a 
Δ31 ENSMUST00000093967 TC1707207 CF173556, AK146526 
Liprin-α2    
6 ENSMUST00000029404 TC1583316 CV559156, CA328790a 
Δ6 - CV558903 CV558903 
Liprin α3    
23 ENSMUST00000003961 TC1581164 AK147645, NM_029741a 
Δ23 - CB249091 - 
Liprin-α4    
22   BY703827 (nur E22+23)  
Δ22 ENSMUST00000027729 TC1601776 BG080124 
 
28 - - AK170782 
Δ28 ENSMUST00000027729 NP747047, 
TC1621807 
AK003571, XM_988391a 
Data are based on the anaylsis of EST sequences in the UCSC, GenBank, ENSEMBL, and TIGR databases. Δ  marks 
variants, in which the exon is absent. a, databases contain additional EST sequences for this transcript variant. 
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